{"result_id": "134032", "URL": "https://www.globalresearch.ca/covid-19-vaccines-scientific-proof-lethality/5767711", "timestamp": "2023-04-25 15:17:38 CEST+0200", "meta": {"description": "", "lang": "en", "keywords": "", "favicon": "https://www.globalresearch.ca/favicon2.ico", "canonical": "https://www.globalresearch.ca/covid-19-vaccines-scientific-proof-lethality/5767711", "encoding": "UTF-8"}, "image": null, "domain": "www.globalresearch.ca", "title": "COVID-19 Vaccines: Proof of Lethality. Over One Thousand Scientific Studies", "cleaned_text": "All Global Research articles can be read in 51 languages by activating the \u201cTranslate Website\u201d drop down menu on the top banner of our home page (Desktop version).\n\nVisit and follow us on Instagram at @globalresearch_crg.\n\nFirst published by Global Research on January 21, 2022\n\nSince the publication of this article, the number of studies has increased. The evidence is overwhelming.\n\nOver One Thousand Scientific Studies Prove That the COVID-19 Vaccines Are Dangerous, and All Those Pushing This Agenda Are Committing the Indictable Crime of Gross Misconduct in Public Office\n\nJust over 12 months from deployment of the COVID 19 emergency use experimental vaccines, scientific studies in the thousands, and reports of criminal complaints of assault and murder from the illegal, unlawful use of biochemical poisons made to police forces around the country, verify an assault on an unsuspecting UK population. Irrefutable science shows that the COVID 19 vaccine is not safe and not effective in limiting transmission or infection from the SARS-CoV-2, coronavirus pathogens.\n\nThe \u201csafe and effective\u201d false propaganda, put out by public officials who now are continuing to push this vaccine, is a clear breach of duty. A public office holder is subject to, and aware of, a duty to prevent death or serious injury that arises only by virtue of the functions of the public office.\n\nMany have breached that duty and, in doing so, are recklessly causing a risk of death or serious injury, by carrying on regardless of the now-confirmed dangers associated with COVID 19 injections. Some of these risks are blood clotting, myocarditis, pericarditis, thrombosis, thrombocytopenia, anaphylaxis, Bell\u2019s palsy, Guillain-Barre, cancer including deaths, etc.\n\nAll of these are confirmed in the following science-and-government-gathered data from the UK Health and Security agency on COVID 19 regarding vaccine damage.\n\nThe term \u201cvaccine\u201d was changed recently to incorporate this illegal, unlawful medical experiment to facilitate usage of mRNA technology that is demonstrably not a vaccine, and which contains biologically toxic nano-metamaterials associated with 5G urban data gathering capability.\n\nMetal nanoparticulates are known in science to be genotoxic\u2014a poison that can also cause sterilization. The dangers posed to the victims in the near term from this medical battery are now known. However, the long term lethality of this weapon is not as yet realized due to the debilitating effects it has on the immune system, causing Acquired Immunodeficiency Syndrome(AIDS).\n\nThe Medicines and Healthcare (products) Regulatory Agency (MHRA) had prior warning of the expected large numbers of adverse reactions before the deployment\u2014confirming the premeditated nature of the crime and public conduct offences then and now.\n\u2022 Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/\n\u2022 Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: https://www.sciencedirect.com/science/article/pii/S1052305721003414\n\u2022 Three cases of acute venous thromboembolism in women after vaccination against COVID-19: https://www.sciencedirect.com/science/article/pii/S2213333X21003929\n\u2022 Acute thrombosis of the coronary tree after vaccination against COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988\n\u2022 US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020: https://pubmed.ncbi.nlm.nih.gov/33929487/\n\u2022 Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET): https://pubmed.ncbi.nlm.nih.gov/33871350/\n\u2022 Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review: https://www.sciencedirect.com/science/article/pii/S0022510X21003014\n\u2022 Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381\n\u2022 Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma: https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505\n\u2022 Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904\n\u2022 COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis: https://www.sciencedirect.com/science/article/pii/S1665268121000557\n\u2022 The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): https://www.sciencedirect.com/science/article/pii/S1050173821000967\n\u2022 Roots of autoimmunity of thrombotic events after COVID-19 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160\n\u2022 Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in \u201c23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine\u201d: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601\n\u2022 Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article\n\u2022 Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\n\u2022 Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://www.sciencedirect.com/science/article/pii/S0264410X21005247\n\u2022 Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination: https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478\n\u2022 Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005\n\u2022 Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895\n\u2022 Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination: https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315\n\u2022 Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data: https://www.sciencedirect.com/science/article/pii/S0896841121000937\n\u2022 Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://www.sciencedirect.com/science/article/pii/S0953620521002363\n\u2022 Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers: https://www.sciencedirect.com/science/article/pii/S0828282X21006243\n\u2022 \u201cPortal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome\u201d: https://www.sciencedirect.com/science/article/pii/S2666572721000389\n\u2022 Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S0196064421003425\n\u2022 Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706\n\u2022 Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin based anticoagulation: https://www.sciencedirect.com/science/article/pii/S1871402121002046\n\u2022 Thrombosis after COVID-19 vaccination: possible link to ACE pathways: https://www.sciencedirect.com/science/article/pii/S0049384821004369\n\u2022 Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://www.sciencedirect.com/science/article/pii/S0735109721051949\n\u2022 A rare case of a middle-aged Asian male with cerebral venous thrombosis after AstraZeneca COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0735675721005714\n\u2022 Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X\n\u2022 Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel\u2019s back?: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ\n\u2022 Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis?: https://www.sciencedirect.com/science/article/pii/S0953620521002314\n\u2022 Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination: https://www.sciencedirect.com/science/article/pii/S0213485321000839\n\u2022 Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the \u201cAstraZeneca COVID-19 vaccine\u201d: https://pubmed.ncbi.nlm.nih.gov/33918932/\n\u2022 COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase: https://pubmed.ncbi.nlm.nih.gov/33863748/\n\u2022 Cerebral venous thrombosis associated with the covid-19 vaccine in Germany: https://onlinelibrary.wiley.com/doi/10.1002/ana.26172\n\u2022 Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event: https://pubmed.ncbi.nlm.nih.gov/34133027/\n\u2022 The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34001390/\n\u2022 Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\n\u2022 First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://www.nature.com/articles/s41591-021-01408-4\n\u2022 First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105244/\n\u2022 COVID-19 Vaccination Associated with Myocarditis in Adolescents: https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf\n\u2022 Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://pubmed.ncbi.nlm.nih.gov/33994339/\n\u2022 Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature: https://www.sciencedirect.com/science/article/pii/S1553838921005789\n\u2022 COVID-19 vaccine-induced myocarditis: a case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121002253\n\u2022 Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X\n\u2022 Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.sciencedirect.com/science/article/pii/S002234762100617X\n\u2022 Fulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://www.sciencedirect.com/science/article/pii/S0167527321012286.\n\u2022 Myocarditis following vaccination with BNT162b2 in a healthy male: https://www.sciencedirect.com/science/article/pii/S0735675721005362\n\u2022 Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection: https://www.sciencedirect.com/science/article/pii/S1930043321005549\n\u2022 Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection: https://www.sciencedirect.com/science/article/pii/S2352906721000622\n\u2022 Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age: https://www.sciencedirect.com/science/article/pii/S0022347621007368\n\u2022 Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: https://www.sciencedirect.com/science/article/pii/S0022347621007496\n\u2022 A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://www.sciencedirect.com/science/article/pii/S1936878X21004861\n\u2022 Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e/en/covidwho-1360706.\n\u2022 Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines\n\u2022 Association of myocarditis with COVID-19 mRNA vaccine in children: https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children/\n\u2022 Association of myocarditis with COVID-19 messenger RNA vaccine BNT162b2 in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\n\u2022 Myocarditis after immunization with COVID-19 mRNA vaccines in members of the U.S. military: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C\n\u2022 Myocarditis associated with vaccination with COVID-19 mRNA: https://pubs.rsna.org/doi/10.1148/radiol.2021211430\n\u2022 Cardiovascular magnetic resonance imaging findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4\n\u2022 Clinical Guidance for Young People with Myocarditis and Pericarditis after Vaccination with COVID-19 mRNA: https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis\n\u2022 Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\n\u2022 Case report: acute myocarditis after second dose of mRNA-1273 SARS-CoV-2 mRNA vaccine: https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567\n\u2022 The new COVID-19 mRNA vaccine platform and myocarditis: clues to the possible underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34312010/\n\u2022 Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the Vaccine Adverse Event Reporting System database: https://pubmed.ncbi.nlm.nih.gov/34219532/\n\u2022 Be alert to the risk of adverse cardiovascular events after COVID-19 vaccination: https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033\n\u2022 Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac tomography, and magnetic resonance imaging findings: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236\n\u2022 In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038\n\u2022 Occurrence of acute infarct-like myocarditis after COVID-19 vaccination: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?: https://pubmed.ncbi.nlm.nih.gov/34333695/\n\u2022 Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/\n\u2022 Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\n\u2022 Biopsy-proven lymphocytic myocarditis after first COVID-19 mRNA vaccination in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\n\u2022 Insights from a murine model of COVID-19 mRNA vaccine-induced myopericarditis: could accidental intravenous injection of a vaccine induce myopericarditis https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059\n\u2022 Perimyocarditis after the first dose of mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 vaccine in a young healthy male: case report: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183\n\u2022 Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or causal relationship: https://pubmed.ncbi.nlm.nih.gov/34236331/\n\u2022 Rhabdomyolysis and fasciitis induced by the COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34435250/\n\u2022 GM1 ganglioside antibody and COVID-19-related Guillain Barre syndrome: case report, systemic review, and implications for vaccine development: https://www.sciencedirect.com/science/article/pii/S2666354621000065\n\u2022 Sensory Guillain-Barr\u00e9 syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://www.sciencedirect.com/science/article/pii/S0165572821002186\n\u2022 Guillain-Barr\u00e9 syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://www.sciencedirect.com/science/article/pii/S2214250921000998.\n\u2022 Guillain-Barr\u00e9 syndrome presenting as facial diplegia after vaccination with COVID-19: a case report: https://www.sciencedirect.com/science/article/pii/S0736467921006442\n\u2022 Guillain-Barr\u00e9 syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://www.sciencedirect.com/science/article/pii/S0035378721005853.\n\u2022 SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination: https://www.sciencedirect.com/science/article/pii/S2049080121005343\n\u2022 Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report: https://www.sciencedirect.com/science/article/pii/S2049080121007536\n\u2022 Facial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database: https://www.sciencedirect.com/science/article/pii/S1201971221007049\n\u2022 Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence: https://www.sciencedirect.com/science/article/pii/S0899707121003557.\n\u2022 Bell\u2019s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell\u2019s palsy: https://www.sciencedirect.com/science/article/pii/S266635462100020X\n\u2022 An academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient\u2019s allergy history: https://www.sciencedirect.com/science/article/pii/S2213219821007972\n\u2022 COVID-19 vaccine-induced rhabdomyolysis: case report with review of the literature: https://www.sciencedirect.com/science/article/pii/S1871402121001880\n\u2022 Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://www.sciencedirect.com/science/article/pii/S0190962221024427\n\u2022 Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381.\n\u2022 COVID-19 vaccine-associated anaphylaxis: a statement from the Anaphylaxis Committee of the World Allergy Organization:. https://www.sciencedirect.com/science/article/pii/S1939455121000119.\n\u2022 Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in an elderly, non-comorbid Indian male treated with conventional heparin-warfarin-based anticoagulation:. https://www.sciencedirect.com/science/article/pii/S1871402121002046.\n\u2022 Acute myocarditis after administration of BNT162b2 vaccine against COVID-19:. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X\n\u2022 Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccine: an analysis of European data:. https://www.sciencedirect.com/science/article/pii/S0896841121000937.\n\u2022 Bullous drug eruption after the second dose of COVID-19 mRNA-1273 (Moderna) vaccine: Case report: https://www.sciencedirect.com/science/article/pii/S1876034121001878.\n\u2022 COVID-19 RNA-based vaccines and the risk of prion disease: https://scivisionpub.com/pdfs/covid19rna-based-vaccines-and-the-risk-of-prion-dis ease-1503.pdf\n\u2022 This study notes that 115 pregnant women lost their babies, out of 827 who participated in a study on the safety of covid-19 vaccines: https://www.nejm.org/doi/full/10.1056/NEJMoa2104983.\n\u2022 Allergic reactions, including anaphylaxis, after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33475702/\n\u2022 Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol: https://pubmed.ncbi.nlm.nih.gov/33320974/\n\u2022 Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine \u2013 United States, December 14-23, 2020: https://pubmed.ncbi.nlm.nih.gov/33444297/\n\u2022 Allergic reactions, including anaphylaxis, after receiving first dose of Modern COVID-19 vaccine \u2013 United States, December 21, 2020-January 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33507892/\n\u2022 Reports of anaphylaxis after receiving COVID-19 mRNA vaccines in the U.S.-Dec 14, 2020-Jan 18, 2021: https://pubmed.ncbi.nlm.nih.gov/33576785/\n\u2022 Immunization practices and risk of anaphylaxis: a current, comprehensive update of COVID-19 vaccination data: https://pubmed.ncbi.nlm.nih.gov/34269740/\n\u2022 Relationship between pre-existing allergies and anaphylactic reactions following administration of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34215453/\n\u2022 Anaphylaxis Associated with COVID-19 mRNA Vaccines: Approach to Allergy Research: https://pubmed.ncbi.nlm.nih.gov/33932618/\n\u2022 Severe Allergic Reactions after COVID-19 Vaccination with the Pfizer / BioNTech Vaccine in Great Britain and the USA: Position Statement of the German Allergy Societies: German Medical Association of Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA): https://pubmed.ncbi.nlm.nih.gov/33643776/\n\u2022 Reported orofacial adverse effects from COVID-19 vaccines: the known and the unknown: https://pubmed.ncbi.nlm.nih.gov/33527524/\n\u2022 Cumulative adverse event report of anaphylaxis following injections of COVID-19 mRNA vaccine (Pfizer-BioNTech) in Japan: the first month report: https://pubmed.ncbi.nlm.nih.gov/34347278/\n\u2022 Biphasic anaphylaxis after exposure to the first dose of the Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/\n\u2022 Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation: https://pubmed.ncbi.nlm.nih.gov/33657648/\n\u2022 Polyethylene glycol (PEG) is a cause of anaphylaxis to Pfizer / BioNTech mRNA COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33825239/\n\u2022 Polyethylene glycole allergy of the SARS CoV2 vaccine recipient: case report of a young adult recipient and management of future exposure to SARS-CoV2: https://pubmed.ncbi.nlm.nih.gov/33919151/\n\u2022 Elevated rates of anaphylaxis after vaccination with Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers; a secondary analysis of initial post-approval safety data: https://pubmed.ncbi.nlm.nih.gov/34128049/\n\u2022 Allergic reactions and adverse events associated with administration of mRNA-based vaccines. A health system experience: https://pubmed.ncbi.nlm.nih.gov/34474708/\n\u2022 Allergic reactions to COVID-19 vaccines: statement of the Belgian Society of Allergy and Clinical Immunology (BelSACI): https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447\n\u2022 .IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis to COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34318537/\n\u2022 Allergic reactions after COVID-19 vaccination: putting the risk in perspective: https://pubmed.ncbi.nlm.nih.gov/34463751/\n\u2022 Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: https://pubmed.ncbi.nlm.nih.gov/33846043/ 188.\n\u2022 Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts: https://pubmed.ncbi.nlm.nih.gov/33752263/\n\u2022 COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\n\u2022 A case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/\n\u2022 Skin reactions reported after Moderna and Pfizer\u2019s COVID-19 vaccination: a study based on a registry of 414 cases: https://pubmed.ncbi.nlm.nih.gov/33838206/\n\u2022 Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: https://pubmed.ncbi.nlm.nih.gov/34517079/\n\u2022 Skin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases: https://pubmed.ncbi.nlm.nih.gov/34254291/\n\u2022 Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry: https://pubmed.ncbi.nlm.nih.gov/34487581/\n\u2022 Immune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome: https://pubmed.ncbi.nlm.nih.gov/33987882/\n\u2022 Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\n\u2022 Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\n\u2022 Nerve and muscle adverse events after vaccination with COVID-19: a systematic review and meta-analysis of clinical trials: https://pubmed.ncbi.nlm.nih.gov/34452064/.\n\u2022 A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated with administration of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33917902/\n\u2022 Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): https://pubmed.ncbi.nlm.nih.gov/34256983/\n\u2022 Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\n\u2022 Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/\n\u2022 59-year-old woman with extensive deep venous thrombosis and pulmonary thromboembolism 7 days after a first dose of Pfizer-BioNTech BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34117206/\n\u2022 Cerebral venous thrombosis and vaccine-induced thrombocytopenia.a. Oxford-AstraZeneca COVID-19: a missed opportunity for a rapid return on experience: https://pubmed.ncbi.nlm.nih.gov/34033927/\n\u2022 Myocarditis and other cardiovascular complications of mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\n\u2022 Unusual presentation of acute pericarditis after vaccination against SARS-COV-2 mRNA-1237 Modern: https://pubmed.ncbi.nlm.nih.gov/34447639/\n\u2022 Case report: acute myocarditis after second dose of SARS-CoV-2 mRNA-1273 vaccine mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34514306/\n\u2022 Immune-mediated disease outbreaks or recent-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\n\u2022 Insights from a murine model of myopericarditis induced by COVID-19 mRNA vaccine: could accidental intravenous injection of a vaccine induce myopericarditis: https://pubmed.ncbi.nlm.nih.gov/34453510/\n\u2022 Thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination: risk-benefit analysis for persons <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\n\u2022 The association between COVID-19 vaccination and Bell\u2019s palsy: https://pubmed.ncbi.nlm.nih.gov/34411533/\n\u2022 Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 vaccine (AZD1222): https://pubmed.ncbi.nlm.nih.gov/33981305/\n\u2022 Sequential contralateral facial nerve palsy after first and second doses of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34281950/.\n\u2022 Facial nerve palsy after administration of COVID-19 mRNA vaccines: analysis of self-report database: https://pubmed.ncbi.nlm.nih.gov/34492394/\n\u2022 Transient oculomotor paralysis after administration of RNA-1273 messenger vaccine for SARS-CoV-2 diplopia after COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34369471/\n\u2022 A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy following ChAdOx1 nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34272622/\n\u2022 Guillian Barr\u00e9 syndrome after vaccination with mRNA-1273 against COVID-19: https://pubmed.ncbi.nlm.nih.gov/34477091/\n\u2022 Acute facial paralysis as a possible complication of SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33975372/.\n\u2022 Bell\u2019s palsy after COVID-19 vaccination with high antibody response in CSF: https://pubmed.ncbi.nlm.nih.gov/34322761/.\n\u2022 Parsonage-Turner syndrome associated with SARS-CoV-2 or SARS-CoV-2 vaccination. Comment on: \u201cNeuralgic amyotrophy and COVID-19 infection: 2 cases of accessory spinal nerve palsy\u201d by Coll et al. Articular Spine 2021; 88: 10519: https://pubmed.ncbi.nlm.nih.gov/34139321/.\n\u2022 Acute autoimmune-like hepatitis with atypical antimitochondrial antibody after vaccination with COVID-19 mRNA: a new clinical entity: https://pubmed.ncbi.nlm.nih.gov/34293683/.\n\u2022 A novel case of bifacial diplegia variant of Guillain-Barr\u00e9 syndrome after vaccination with Janssen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34449715/\n\u2022 Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: https://pubmed.ncbi.nlm.nih.gov/34139631/.\n\u2022 Bilateral superior ophthalmic vein thrombosis, ischemic stroke and immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/33864750/\n\u2022 Diagnosis and treatment of cerebral venous sinus thrombosis with vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33914590/\n\u2022 Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\n\u2022 Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and positive SARS-CoV-2 tests: self-controlled case series study: https://pubmed.ncbi.nlm.nih.gov/34446426/\n\u2022 Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34174723/\n\u2022 Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\n\u2022 First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\n\u2022 Cerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/\n\u2022 Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\n\u2022 celiac artery and splenic artery thrombosis complicated by splenic infarction 7 days after the first dose of Oxford vaccine, causal relationship or coincidence: https://pubmed.ncbi.nlm.nih.gov/34261633/.\n\u2022 Cerebral venous sinus thrombosis associated with thrombocytopenia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33845870/.\n\u2022 central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\n\u2022 Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: https://pubmed.ncbi.nlm.nih.gov/34402235/\n\u2022 Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\n\u2022 Cerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/\n\u2022 A case of multiple thrombocytopenia and thrombosis following vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34137813/\n\u2022 Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines: https://pubmed.ncbi.nlm.nih.gov/34191218/\n\u2022 Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: https://pubmed.ncbi.nlm.nih.gov/34092488/\n\u2022 Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34132839/.\n\u2022 Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/33687691/\n\u2022 Procoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34011137/.\n\u2022 Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/.\n\u2022 Atypical thrombosis associated with the vaccine VaxZevria\u00ae (AstraZeneca): data from the French network of regional pharmacovigilance centers: https://pubmed.ncbi.nlm.nih.gov/34083026/.\n\u2022 Acute cerebral venous thrombosis and pulmonary artery embolism associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34247246/.\n\u2022 Cutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\n\u2022 Thrombotic thrombocytopenia after vaccination with COVID-19: in search of the underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34071883/\n\u2022 Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites: https://pubmed.ncbi.nlm.nih.gov/34375510/\n\u2022 Severe vaccine-induced thrombotic thrombocytopenia following vaccination with COVID-19: an autopsy case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34355379/.\n\u2022 A case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA: https://pubmed.ncbi.nlm.nih.gov/34452028/\n\u2022 Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\n\u2022 Acquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34105247/.\n\u2022 Sensory Guillain-Barr\u00e9 syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34416410/.\n\u2022 Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34224024/.\n\u2022 Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence?: https://pubmed.ncbi.nlm.nih.gov/34507266/\n\u2022 Fatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma: https://pubmed.ncbi.nlm.nih.gov/34459725/\n\u2022 Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\n\u2022 Three cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome: https://pubmed.ncbi.nlm.nih.gov/34043800/.\n\u2022 Facial diplegia: a rare and atypical variant of Guillain-Barr\u00e9 syndrome and the Ad26.COV2.S vaccine: https://pubmed.ncbi.nlm.nih.gov/34447646/\n\u2022 fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: https://pubmed.ncbi.nlm.nih.gov/34416319/.\n\u2022 Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\n\u2022 Induction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/\n\u2022 Petechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34513435/\n\u2022 Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech COVID-19 vaccine in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34513446/\n\u2022 Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO \u00d7 1 nCov-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34474550/\n\u2022 Two cases of Graves\u2019 disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants: https://pubmed.ncbi.nlm.nih.gov/33858208/\n\u2022 Acute relapse and impaired immunization after COVID-19 vaccination in a patient with multiple sclerosis treated with rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/\n\u2022 Transient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: https://pubmed.ncbi.nlm.nih.gov/34516272/.\n\u2022 Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: case report: https://pubmed.ncbi.nlm.nih.gov/34512961/\n\u2022 Lymphohistocytic myocarditis after vaccination with the COVID-19 viral vector Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/\n\u2022 IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/\n\u2022 A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34196469/.\n\u2022 Onset / outbreak of psoriasis after Corona virus ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: https://pubmed.ncbi.nlm.nih.gov/34350668/\n\u2022 Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/.\n\u2022 Report of the International Cerebral Venous Thrombosis Consortium on cerebral venous thrombosis after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34462996/\n\u2022 Immune thrombocytopenia after vaccination during the COVID-19 pandemic: https://pubmed.ncbi.nlm.nih.gov/34435486/\n\u2022 COVID-19: lessons from the Norwegian tragedy should be taken into account in planning for vaccine launch in less developed/developing countries: https://pubmed.ncbi.nlm.nih.gov/34435142/\n\u2022 Rituximab-induced acute lympholysis and pancytopenia following vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34429981/\n\u2022 Exacerbation of plaque psoriasis after COVID-19 inactivated mRNA and BNT162b2 vaccines: report of two cases: https://pubmed.ncbi.nlm.nih.gov/34427024/\n\u2022 Vesiculobullous cutaneous reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34236711/\n\u2022 Acute perimyocarditis after the first dose of COVID-19 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34515024/\n\u2022 Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34363637/\n\u2022 Immune thrombocytopenia associated with the Pfizer-BioNTech COVID-19 mRNA vaccine BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921002018\n\u2022 Collection of complement-mediated and autoimmune-mediated hematologic conditions after SARS-CoV-2 vaccination: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic\n\u2022 Petechial rash associated with CoronaVac vaccination: first report of cutaneous side effects before phase 3 results: https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794\n\u2022 Cerebral venous thrombosis associated with COVID-19 vaccine in Germany: https://pubmed.ncbi.nlm.nih.gov/34288044/.\n\u2022 Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: https://pubmed.ncbi.nlm.nih.gov/33857630/.\n\u2022 The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune-immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34455073/\n\u2022 Cerebral venous sinus thrombosis in the U.S. population, After SARS-CoV-2 vaccination with adenovirus and after COVID-19: https://pubmed.ncbi.nlm.nih.gov/34116145/\n\u2022 Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular administration of the vaccine: https://pubmed.ncbi.nlm.nih.gov/34286453/.\n\u2022 Central venous sinus thrombosis with subarachnoid hemorrhage after COVID-19 mRNA vaccination: are these reports merely coincidental: https://pubmed.ncbi.nlm.nih.gov/34478433/\n\u2022 Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first brain MRI: https://pubmed.ncbi.nlm.nih.gov/34244448/\n\u2022 Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34226070/\n\u2022 Cerebral venous sinus thrombosis associated with post-vaccination thrombocytopenia by COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/.\n\u2022 Cerebral venous sinus thrombosis 2 weeks after the first dose of SARS-CoV-2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34101024/.\n\u2022 Adenovirus interactions with platelets and coagulation and vaccine-associated autoimmune thrombocytopenia thrombosis syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/.\n\u2022 Headache attributed to COVID-19 (SARS-CoV-2 coronavirus) vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study: https://pubmed.ncbi.nlm.nih.gov/34313952/\n\u2022 Adverse effects reported after COVID-19 vaccination in a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/\n\u2022 Cerebral venous sinus thrombosis following vaccination against SARS-CoV-2: an analysis of cases reported to the European Medicines Agency: https://pubmed.ncbi.nlm.nih.gov/34293217/\n\u2022 A rare case of a middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34274191/\n\u2022 Cerebral venous sinus thrombosis negative for anti-PF4 antibody without thrombocytopenia after immunization with COVID-19 vaccine in a non-comorbid elderly Indian male treated with conventional heparin-warfarin-based anticoagulation: https://pubmed.ncbi.nlm.nih.gov/34186376/\n\u2022 Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/33952445/\n\u2022 Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34129181/\n\u2022 S. case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S, March 2-April 21, 2021: https://pubmed.ncbi.nlm.nih.gov/33929487/.\n\u2022 Malignant cerebral infarction after vaccination with ChAdOx1 nCov-19: a catastrophic variant of vaccine-induced immune-mediated thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34341358/\n\u2022 Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\n\u2022 Autoimmunity roots of thrombotic events after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/\n\u2022 Massive cerebral venous thrombosis and venous basin infarction as late complications of COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34373991/\n\u2022 Australian and New Zealand approach to the diagnosis and treatment of vaccine-induced immune thrombosis and immune thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34490632/\n\u2022 An observational study to identify the prevalence of thrombocytopenia and anti-PF4 / polyanion antibodies in Norwegian health care workers after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33909350/\n\u2022 Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 serious adverse events of post-vaccination ATM with ChAdOx1 nCoV-19 (AZD1222) vaccine: https://pubmed.ncbi.nlm.nih.gov/33981305/.\n\u2022 A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/34272622/\n\u2022 Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine:. https://pubmed.ncbi.nlm.nih.gov/33877737/\n\u2022 Predicted and observed incidence of thromboembolic events among Koreans vaccinated with the ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34254476/\n\u2022 First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: https://pubmed.ncbi.nlm.nih.gov/34108714/\n\u2022 ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107,720 doses of ChAdOx1 vaccination in Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/.\n\u2022 Neurosurgical considerations with respect to decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/\n\u2022 Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/\n\u2022 A rare case of thrombosis and thrombocytopenia of the superior ophthalmic vein after ChAdOx1 nCoV-19 vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34276917/\n\u2022 Limb ischemia and pulmonary artery thrombosis after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): a case of vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/33990339/.\n\u2022 Secondary thrombocytopenia after SARS-CoV-2 vaccination: case report of haemorrhage and hematoma after minor oral surgery: https://pubmed.ncbi.nlm.nih.gov/34314875/.\n\u2022 Venous thromboembolism and mild thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/\n\u2022 Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after successful initial therapy with intravenous immunoglobulins: a rationale for monitoring immunoglobulin G levels: https://pubmed.ncbi.nlm.nih.gov/34382387/\n\u2022 A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/.\n\u2022 Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\n\u2022 Cutaneous thrombosis associated with cutaneous necrosis following Oxford-AstraZeneca COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34189756/\n\u2022 Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\n\u2022 Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1\n\u2022 Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in a mouse model: https://t.co/j0IEM8cMXI\n\u2022 A report of myocarditis adverse events in the U.S. Vaccine Adverse Event Reporting System. (VAERS) in association with COVID-19 injectable biologics: https://pubmed.ncbi.nlm.nih.gov/34601006/\n\u2022 This study concludes that: \u201cThe vaccine was associated with an excess risk of myocarditis (1 to 5 events per 100,000 persons). The risk of this potentially serious adverse event and of many other serious adverse events increased substantially after SARS-CoV-2 infection\u201d: https://www.nejm.org/doi/full/10.1056/NEJMoa2110475\n\u2022 Myocarditis associated with SARS-CoV-2 mRNA vaccination in children aged 12 to 17 years: stratified analysis of a national database: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.\n\u2022 Immune-mediated hepatitis with the Moderna vaccine is no longer a coincidence but confirmed: https://www.sciencedirect.com/science/article/pii/S0168827821020936\n\u2022 Lobar hemorrhage with ventricular rupture shortly after the first dose of an mRNA-based SARS-CoV-2 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/\n\u2022 Mrna COVID vaccines dramatically increase endothelial inflammatory markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: a caution: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712\n\u2022 ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome:https://www.science.org/doi/10.1126/sciadv.abl8213\n\u2022 Lethal vaccine-induced immune thrombotic immune thrombocytopenia (VITT) following announcement 26.COV2.S: first documented case outside the U.S.: https://pubmed.ncbi.nlm.nih.gov/34626338/\n\u2022 Treatment of acute ischemic stroke associated with ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34461442/\n\u2022 Portal vein thrombosis due to vaccine-induced immune thrombotic immune thrombocytopenia (VITT) after Covid vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34598301/\n\u2022 Myocardial infarction and azygos vein thrombosis after vaccination with ChAdOx1 nCoV-19 in a hemodialysis patient: https://pubmed.ncbi.nlm.nih.gov/34650896/\n\u2022 Humoral response induced by Prime-Boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines in a patient with multiple sclerosis treated with teriflunomide: https://pubmed.ncbi.nlm.nih.gov/34696248/\n\u2022 Predictors of mortality in thrombotic thrombocytopenia after adenoviral COVID-19 vaccination: the FAPIC score: https://pubmed.ncbi.nlm.nih.gov/34545400/\n\u2022 Ischemic stroke as a presenting feature of immune thrombotic thrombocytopenia induced by ChAdOx1-nCoV-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34035134/\n\u2022 In-hospital observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34688190/\n\u2022 Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: report of three cases: https://pubmed.ncbi.nlm.nih.gov/34782400/\n\u2022 Cardiovascular, neurological, and pulmonary events after vaccination with BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data: https://pubmed.ncbi.nlm.nih.gov/34710832/\n\u2022 Cerebral venous thrombosis developing after vaccination. COVID-19: VITT, VATT, TTS and more: https://pubmed.ncbi.nlm.nih.gov/34695859/\n\u2022 Possible triggers of thrombocytopenia and/or hemorrhage by BNT162b2 vaccine, Pfizer-BioNTech: https://pubmed.ncbi.nlm.nih.gov/34660652/.\n\u2022 Multiple sites of arterial thrombosis in a 35-year-old patient after vaccination with ChAdOx1 (AstraZeneca), which required emergency femoral and carotid surgical thrombectomy: https://pubmed.ncbi.nlm.nih.gov/34644642/\n\u2022 Neuro-ophthalmic complications with thrombocytopenia and thrombosis induced by ChAdOx1 nCoV-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34726934/\n\u2022 Thrombotic events after COVID-19 vaccination in over 50 years of age: results of a population-based study in Italy: https://pubmed.ncbi.nlm.nih.gov/34835237/\n\u2022 Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia after ChAdOx1 nCOVID-19 vaccination in a pregnant woman: https://pubmed.ncbi.nlm.nih.gov/34261297/\n\u2022 Age- and sex-specific incidence of cerebral venous sinus thrombosis associated with Ad26.COV2.S COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34724036/.\n\u2022 Genital necrosis with cutaneous thrombosis following vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34839563/\n\u2022 COVID-19 vaccine-induced immune thrombosis with thrombocytopenia thrombosis (VITT) and shades of gray in thrombus formation: https://pubmed.ncbi.nlm.nih.gov/34624910/\n\u2022 A rare case of COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) affecting the venosplanchnic and pulmonary arterial circulation from a UK district general hospital: https://pubmed.ncbi.nlm.nih.gov/34535492/\n\u2022 Thrombosis with thrombocytopenia syndrome (TTS) after vaccination with AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: a risk-benefit analysis for persons <60% risk-benefit analysis for people <60 years in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/\n\u2022 Characteristics and outcomes of patients with cerebral venous sinus thrombosis in thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622\n\u2022 Case study of thrombosis and thrombocytopenia syndrome after administration of the AstraZeneca COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34781321/\n\u2022 Thrombosis with Thrombocytopenia Syndrome Associated with COVID-19 Vaccines: https://pubmed.ncbi.nlm.nih.gov/34062319/\n\u2022 Cerebral venous sinus thrombosis following vaccination with ChAdOx1: the first case of definite thrombosis with thrombocytopenia syndrome in India: https://pubmed.ncbi.nlm.nih.gov/34706921/\n\u2022 Case report of immune thrombocytopenia after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34751013/.\n\u2022 Concerns for adverse effects of thrombocytopenia and thrombosis after adenovirus-vectored COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34541935/\n\u2022 Thrombocytopenia with acute ischemic stroke and hemorrhage in a patient recently vaccinated with an adenoviral vector-based COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33877737/\n\u2022 Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34646685/\n\u2022 Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34609603/\n\u2022 Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): https://pubmed.ncbi.nlm.nih.gov/34006408/\n\u2022 A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?: https://pubmed.ncbi.nlm.nih.gov/34416184/\n\u2022 Vaccine-induced immune thrombosis and thrombocytopenia syndrome after adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a new hypothesis on mechanisms and implications for future vaccine development: https://pubmed.ncbi.nlm.nih.gov/34664303/.\n\u2022 Thrombosis in peripheral artery disease and thrombotic thrombocytopenia following adenoviral COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34649281/.\n\u2022 Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34610990/.\n\u2022 Sweet\u2019s syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34590397/\n\u2022 Prevalence of serious adverse events among health care professionals after receiving the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021: https://pubmed.ncbi.nlm.nih.gov/34819146/.\n\u2022 Recurrence of alopecia areata after covid-19 vaccination: a report of three cases in Italy: https://pubmed.ncbi.nlm.nih.gov/34741583/\n\u2022 Shingles-like skin lesion after vaccination with AstraZeneca for COVID-19: a case report: https://pubmed.ncbi.nlm.nih.gov/34631069/\n\u2022 Thrombosis after COVID-19 vaccination: possible link to ACE pathways: https://pubmed.ncbi.nlm.nih.gov/34479129/\n\u2022 Thrombocytopenia in an adolescent with sickle cell anemia after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34331506/\n\u2022 Abdominal pain and bilateral adrenal hemorrhage from immune thrombotic thrombocytopenia induced by COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34546343/\n\u2022 A case of toxic epidermal necrolysis after vaccination with ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34751429/.\n\u2022 Recurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients: https://pubmed.ncbi.nlm.nih.gov/34755433/\n\u2022 Rare case of contralateral supraclavicular lymphadenopathy after vaccination with COVID-19: computed tomography and ultrasound findings: https://pubmed.ncbi.nlm.nih.gov/34667486/\n\u2022 Cutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality: https://pubmed.ncbi.nlm.nih.gov/34726187/.\n\u2022 Understanding the risk of thrombosis with thrombocytopenia syndrome following Ad26.COV2.S vaccination: https://pubmed.ncbi.nlm.nih.gov/34595694/\n\u2022 Cutaneous adverse reactions of 35,229 doses of COVID-19 Sinovac and AstraZeneca vaccine COVID-19: a prospective cohort study in health care workers: https://pubmed.ncbi.nlm.nih.gov/34661934/\n\u2022 Comments on thrombosis after vaccination: spike protein leader sequence could be responsible for thrombosis and antibody-mediated thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34788138\n\u2022 Severe immune thrombocytopenia following COVID-19 vaccination: report of four cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34653943/.\n\u2022 Thrombosis in pre- and post-vaccination phase of COVID-19; https://pubmed.ncbi.nlm.nih.gov/34650382/\n\u2022 A look at the role of postmortem immunohistochemistry in understanding the inflammatory pathophysiology of COVID-19 disease and vaccine-related thrombotic adverse events: a narrative review: https://pubmed.ncbi.nlm.nih.gov/34769454/\n\u2022 An unusual presentation of acute deep vein thrombosis after Modern COVID-19 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34790811/\n\u2022 Immediate high-dose intravenous immunoglobulins followed by direct treatment with thrombin inhibitors is crucial for survival in vaccine-induced immune thrombotic thrombocytopenia Sars-Covid-19-vector adenoviral VITT with venous thrombosis of the cerebral sinus and portal vein: https://pubmed.ncbi.nlm.nih.gov/34023956/.\n\u2022 Imaging and hematologic findings in thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/\n\u2022 Spectrum of neuroimaging findings in post-CoVID-19 vaccination: a case series and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34842783/\n\u2022 Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese man: a case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34630307/\n\u2022 New portal vein thrombosis in cirrhosis: is thrombophilia exacerbated by vaccine or COVID-19: https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext.\n\u2022 Cerebral venous sinus thrombosis after vaccination with COVID-19 mRNA of BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34796065/.\n\u2022 Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccination in health care workers taking ACE inhibitors: https://pubmed.ncbi.nlm.nih.gov/34579248/\n\u2022 A case of unusual mild clinical presentation of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic vein thrombosis: https://pubmed.ncbi.nlm.nih.gov/34843991/\n\u2022 A case of idiopathic thrombocytopenic purpura after a booster dose of COVID-19 BNT162b2 vaccine (Pfizer-Biontech): https://pubmed.ncbi.nlm.nih.gov/34820240/\n\u2022 Thromboembolic events in younger females exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34264151/\n\u2022 Potential risk of thrombotic events after COVID-19 vaccination with Oxford-AstraZeneca in women receiving estrogen: https://pubmed.ncbi.nlm.nih.gov/34734086/\n\u2022 Adenovirus interactions with platelets and coagulation and vaccine-induced immune thrombotic thrombocytopenia syndrome: https://pubmed.ncbi.nlm.nih.gov/34407607/\n\u2022 Unusual site of deep vein thrombosis after vaccination against coronavirus mRNA-2019 coronavirus disease (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34840204/\n\u2022 Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: https://pubmed.ncbi.nlm.nih.gov/34639132/\n\u2022 Isolated pulmonary embolism after COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up: https://pubmed.ncbi.nlm.nih.gov/34804412/\n\u2022 Deep venous thrombosis after vaccination with Ad26.COV2.S in adult males: https://pubmed.ncbi.nlm.nih.gov/34659839/.\n\u2022 Occurrence of COVID-19 variants among recipients of ChAdOx1 nCoV-19 vaccine (recombinant): https://pubmed.ncbi.nlm.nih.gov/34528522/\n\u2022 Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\n\u2022 Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179.\n\u2022 Myocarditis after 2019 coronavirus disease mRNA vaccine: a case series and determination of incidence rate: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408\n\u2022 Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\n\u2022 Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\n\u2022 Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\n\u2022 Myocarditis and other cardiovascular complications of COVID-19 mRNA-based COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34277198/\n\u2022 Possible Association Between COVID-19 Vaccine and Myocarditis: Clinical and CMR Findings: https://pubmed.ncbi.nlm.nih.gov/34246586/\n\u2022 Severe myocarditis associated with COVID-19 vaccine: zebra or unicorn?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext.\n\u2022 Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine in a case series of children: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052\n\u2022 Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed\n\u2022 STEMI mimicry: focal myocarditis in an adolescent patient after COVID-19 mRNA vaccination:. https://pubmed.ncbi.nlm.nih.gov/34756746/\n\u2022 Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/\n\u2022 Myocarditis associated with COVID-19 vaccination in adolescents: https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357\n\u2022 Myocarditis findings on cardiac magnetic resonance imaging after vaccination with COVID-19 mRNA in adolescents:. https://pubmed.ncbi.nlm.nih.gov/34704459/\n\u2022 Acute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/\n\u2022 Case report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34712717/.\n\u2022 Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X.\n\u2022 Myocarditis associated with COVID-19 vaccination: echocardiographic, cardiac CT, and MRI findings:. https://pubmed.ncbi.nlm.nih.gov/34428917/.\n\u2022 Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines:. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/64 42104.\n\u2022 COVID 19 vaccine for adolescents. Concern for myocarditis and pericarditis: https://www.mdpi.com/2036-7503/13/3/61.\n\u2022 Cardiac imaging of acute myocarditis after vaccination with COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34402228/\n\u2022 Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from the vaccine adverse event reporting system database: https://pubmed.ncbi.nlm.nih.gov/34219532/\n\u2022 Acute myocarditis associated with COVID-19 vaccination: report of a case: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/\n\u2022 Myocarditis in the setting of a recent COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34712497/.\n\u2022 Acute myocarditis after a second dose of COVID-19 mRNA vaccine: report of two cases: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.\n\u2022 Prevalence of thrombocytopenia, antiplatelet factor 4 antibodies, and elevated D-dimer in Thais after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/\n\u2022 Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179\n\u2022 Myocarditis and pericarditis after COVID-19 vaccination: inequalities in age and vaccine types: https://www.mdpi.com/2075-4426/11/11/1106\n\u2022 Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: https://pubmed.ncbi.nlm.nih.gov/34402230/\n\u2022 Shedding light on post-vaccination myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: https://pubmed.ncbi.nlm.nih.gov/34696294/\n\u2022 Three cases of acute venous thromboembolism in women after coronavirus 2019 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/\n\u2022 Clinical and biological features of cerebral venous sinus thrombosis after vaccination with ChAdOx1 nCov-19; https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.\n\u2022 COV2-S vaccination may reveal hereditary thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count: https://pubmed.ncbi.nlm.nih.gov/34632750/\n\u2022 Inflammation and platelet activation after COVID-19 vaccines: possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis: https://pubmed.ncbi.nlm.nih.gov/34887867/.\n\u2022 Vaccine-induced cerebral venous thrombosis and thrombocytopenia. Oxford-AstraZeneca COVID-19: a missed opportunity for rapid return on experience: https://www.sciencedirect.com/science/article/pii/S235255682100093X\n\u2022 Occurrence of splenic infarction due to arterial thrombosis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34876440/\n\u2022 Deep venous thrombosis more than two weeks after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33928773/\n\u2022 Case report: Take a second look: Cerebral venous thrombosis related to Covid-19 vaccination and thrombotic thrombocytopenia syndrome: https://pubmed.ncbi.nlm.nih.gov/34880826/\n\u2022 Change in blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome: https://pubmed.ncbi.nlm.nih.gov/34868465/\n\u2022 Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34097311/\n\u2022 Bilateral thalamic stroke: a case of COVID-19 (VITT) vaccine-induced immune thrombotic thrombocytopenia or a coincidence due to underlying risk factors: https://pubmed.ncbi.nlm.nih.gov/34820232/.\n\u2022 Thrombocytopenia and splanchnic thrombosis after vaccination with Ad26.COV2.S successfully treated with transjugular intrahepatic intrahepatic portosystemic shunt and thrombectomy: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258\n\u2022 Incidence of acute ischemic stroke after coronavirus vaccination in Indonesia: case series: https://pubmed.ncbi.nlm.nih.gov/34579636/\n\u2022 Case report: vaccine-induced immune immune thrombotic thrombocytopenia in a patient with pancreatic cancer after vaccination with messenger RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34790684/\n\u2022 Squamous cell carcinoma of the lung with hemoptysis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech): https://pubmed.ncbi.nlm.nih.gov/34612003/\n\u2022 Vaccine-induced thrombotic thrombocytopenia after Ad26.COV2.S vaccination in a man presenting as acute venous thromboembolism: https://pubmed.ncbi.nlm.nih.gov/34096082/\n\u2022 Myocarditis associated with COVID-19 vaccination in three adolescent boys: https://pubmed.ncbi.nlm.nih.gov/34851078/.\n\u2022 Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis after COVID-19 mRNA vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34496880/\n\u2022 Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents after co-vaccination: https://pubmed.ncbi.nlm.nih.gov/34849657/.\n\u2022 Myocarditis-induced sudden death after BNT162b2 COVID-19 mRNA vaccination in Korea: case report focusing on histopathological findings: https://pubmed.ncbi.nlm.nih.gov/34664804/\n\u2022 Acute myocarditis after vaccination with COVID-19 mRNA in adults aged 18 years or older: https://pubmed.ncbi.nlm.nih.gov/34605853/\n\u2022 Recurrence of acute myocarditis temporally associated with receipt of the 2019 coronavirus mRNA disease vaccine (COVID-19) in an adolescent male: https://pubmed.ncbi.nlm.nih.gov/34166671/\n\u2022 Ga-DOTATOC digital PET images of inflammatory cell infiltrates in myocarditis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34746968/\n\u2022 Occurrence of acute infarct-like myocarditis after vaccination with COVID-19: just an accidental coincidence or rather a vaccination-associated autoimmune myocarditis?\u201d: https://pubmed.ncbi.nlm.nih.gov/34333695/.\n\u2022 Self-limited myocarditis presenting with chest pain and ST-segment elevation in adolescents after vaccination with BNT162b2 mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34180390/\n\u2022 Myocarditis Following Immunization with COVID-19 mRNA Vaccines in Members of the U.S. Military: https://pubmed.ncbi.nlm.nih.gov/34185045/\n\u2022 Chest pain with abnormal electrocardiogram redevelopment after injection of COVID-19 vaccine manufactured by Moderna: https://pubmed.ncbi.nlm.nih.gov/34866106/\n\u2022 Biopsy-proven lymphocytic myocarditis after first vaccination with COVID-19 mRNA in a 40-year-old man: case report: https://pubmed.ncbi.nlm.nih.gov/34487236/\n\u2022 Multimodality imaging and histopathology in a young man presenting with fulminant lymphocytic myocarditis and cardiogenic shock after vaccination with mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34848416/\n\u2022 Report of a case of myopericarditis after vaccination with BNT162b2 COVID-19 mRNA in a young Korean male: https://pubmed.ncbi.nlm.nih.gov/34636504/\n\u2022 Acute myocarditis after Comirnaty vaccination in a healthy male with previous SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34367386/\n\u2022 Acute myocarditis in a young adult two days after vaccination with Pfizer: https://pubmed.ncbi.nlm.nih.gov/34709227/\n\u2022 Case report: acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus vaccination in 2019 requiring extracorporeal cardiopulmonary resuscitation: https://pubmed.ncbi.nlm.nih.gov/34778411/\n\u2022 A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34246585/\n\u2022 Post-vaccination multisystem inflammatory syndrome in adults without evidence of prior SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34852213/\n\u2022 Acute myocarditis defined after vaccination with 2019 mRNA of coronavirus disease: https://pubmed.ncbi.nlm.nih.gov/34866122/\n\u2022 Association of myocarditis with COVID-19 messenger RNA BNT162b2 vaccine COVID-19 in a case series of children: https://pubmed.ncbi.nlm.nih.gov/34374740/\n\u2022 Clinical suspicion of myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: https://pubmed.ncbi.nlm.nih.gov/34865500/\n\u2022 Myocarditis following vaccination with Covid-19 in a large healthcare organization: https://pubmed.ncbi.nlm.nih.gov/34614329/\n\u2022 Guillain-Barr\u00e9 syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases: https://pubmed.ncbi.nlm.nih.gov/34796417/.\n\u2022 Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021: https://jamanetwork.com/journals/jama/fullarticle/2785009\n\u2022 Guillain-Barre syndrome after COVID-19 vaccination in an adolescent: https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.\n\u2022 Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients: https://pubmed.ncbi.nlm.nih.gov/34649856/\n\u2022 Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report; https://pubmed.ncbi.nlm.nih.gov/34779385/.\n\u2022 Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34261746/\n\u2022 Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report: https://pubmed.ncbi.nlm.nih.gov/34217513/.\n\u2022 A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34871447/\n\u2022 Reporting of acute inflammatory neuropathies with COVID-19 vaccines: subgroup disproportionality analysis in VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/\n\u2022 A rare variant of Guillain-Barr\u00e9 syndrome after vaccination with Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34703690/.\n\u2022 Guillain-Barr\u00e9 syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barr\u00e9 syndrome: https://pubmed.ncbi.nlm.nih.gov/34810163/\n\u2022 Guillain-Barr\u00e9 syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.\n\u2022 Acute transverse myelitis after SARS-CoV-2 vaccination: case report and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34482455/.\n\u2022 Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine: https://pubmed.ncbi.nlm.nih.gov/34722067/\n\u2022 Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association: https://pubmed.ncbi.nlm.nih.gov/33968610/\n\u2022 SARS-CoV-2 vaccines can be complicated not only by Guillain-Barr\u00e9 syndrome but also by distal small fiber neuropathy: https://pubmed.ncbi.nlm.nih.gov/34525410/\n\u2022 Clinical variant of Guillain-Barr\u00e9 syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine: https://pubmed.ncbi.nlm.nih.gov/34808658/\n\u2022 Adverse event reporting and risk of Bell\u2019s palsy after COVID-19 vaccination: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext.\n\u2022 Left Bell\u2019s palsy after the first dose of mRNA-1273 SARS-CoV-2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34763263/.\n\u2022 Bell\u2019s palsy after inactivated vaccination with COVID-19 in a patient with a history of recurrent Bell\u2019s palsy: case report: https://pubmed.ncbi.nlm.nih.gov/34621891/\n\u2022 Neurological complications after the first dose of COVID-19 vaccines and SARS-CoV-2 infection: https://pubmed.ncbi.nlm.nih.gov/34697502/\n\u2022 Post COVID-19 transverse myelitis; a case report with review of the literature: https://pubmed.ncbi.nlm.nih.gov/34457267/.\n\u2022 Beware of neuromyelitis optica spectrum disorder after vaccination with inactivated virus for COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189662/\n\u2022 Neuromyelitis optica in a healthy woman after vaccination against severe acute respiratory syndrome coronavirus 2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34660149/\n\u2022 Acute bilateral bilateral optic neuritis/chiasm with longitudinal extensive transverse myelitis in long-standing stable multiple sclerosis after vector-based vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34131771/\n\u2022 A case series of acute pericarditis after vaccination with COVID-19 in the context of recent reports from Europe and the United States: https://pubmed.ncbi.nlm.nih.gov/34635376/\n\u2022 Acute pericarditis and cardiac tamponade after vaccination with Covid-19: https://pubmed.ncbi.nlm.nih.gov/34749492/\n\u2022 Myocarditis and pericarditis in adolescents after the first and second doses of COVID-19 mRNA vaccines: https://pubmed.ncbi.nlm.nih.gov/34849667/\n\u2022 Pericarditis after administration of the BNT162b2 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34149145/\n\u2022 An outbreak of Still\u2019s disease after COVID-19 vaccination in a 34-year-old patient: https://pubmed.ncbi.nlm.nih.gov/34797392/\n\u2022 Miller-Fisher syndrome and Guillain-Barr\u00e9 syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34848426/.\n\u2022 Immune-mediated disease outbreaks or new-onset disease in 27 subjects after mRNA/DNA vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/\n\u2022 Post-mortem investigation of deaths after vaccination with COVID-19 vaccines: https://pubmed.ncbi.nlm.nih.gov/34591186/\n\u2022 Acute kidney injury with macroscopic hematuria and IgA nephropathy after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34352309/\n\u2022 Relapse of immune thrombocytopenia after covid-19 vaccination in young male patient: https://pubmed.ncbi.nlm.nih.gov/34804803/.\n\u2022 Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34859017/\n\u2022 Lobar hemorrhage with ventricular rupture shortly after the first dose of a SARS-CoV-2 mRNA-based SARS-CoV-2 vaccine: https://pubmed.ncbi.nlm.nih.gov/34729467/.\n\u2022 A case of outbreak of macroscopic hematuria and IgA nephropathy after SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/33932458/\n\u2022 Acral hemorrhage after administration of the second dose of SARS-CoV-2 vaccine. A post-vaccination reaction: https://pubmed.ncbi.nlm.nih.gov/34092400/742.\n\u2022 Gross hematuria after severe acute respiratory syndrome coronavirus 2 vaccination in 2 patients with IgA nephropathy: https://pubmed.ncbi.nlm.nih.gov/33771584/\n\u2022 COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: https://pubmed.ncbi.nlm.nih.gov/34073536/\n\u2022 Bell\u2019s palsy after vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and a nested case-control study: https://pubmed.ncbi.nlm.nih.gov/34411532/\n\u2022 Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule, and interval: https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1\n\u2022 Anaphylaxis following Covid-19 vaccine in a patient with cholinergic urticaria: https://pubmed.ncbi.nlm.nih.gov/33851711/\n\u2022 Anaphylaxis induced by CoronaVac COVID-19 vaccine: clinical features and results of revaccination: https://pubmed.ncbi.nlm.nih.gov/34675550/.\n\u2022 Association of self-reported history of high-risk allergy with allergy symptoms after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34698847/\n\u2022 Sex differences in the incidence of anaphylaxis to LNP-mRNA vaccines COVID-19: https://pubmed.ncbi.nlm.nih.gov/34020815/\n\u2022 Allergic reactions, including anaphylaxis, after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine \u2013 United States, December 14 to 23, 2020: https://pubmed.ncbi.nlm.nih.gov/33641264/\n\u2022 Allergic reactions, including anaphylaxis, after receiving the first dose of Modern COVID-19 vaccine \u2013 United States, December 21, 2020 to January 10, 2021: https://pubmed.ncbi.nlm.nih.gov/33641268/\n\u2022 Prolonged anaphylaxis to Pfizer 2019 coronavirus disease vaccine: a case report and mechanism of action: https://pubmed.ncbi.nlm.nih.gov/33834172/\n\u2022 Anaphylaxis reactions to Pfizer BNT162b2 vaccine: report of 3 cases of anaphylaxis following vaccination with Pfizer BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34579211/\n\u2022 Biphasic anaphylaxis after first dose of 2019 messenger RNA coronavirus disease vaccine with positive polysorbate 80 skin test result: https://pubmed.ncbi.nlm.nih.gov/34343674/\n\u2022 Takotsubo cardiomyopathy after coronavirus 2019 vaccination in patient on maintenance hemodialysis: https://pubmed.ncbi.nlm.nih.gov/34731486/.\n\u2022 Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in persons aged 75 years or older: https://pubmed.ncbi.nlm.nih.gov/34807248/\n\u2022 Acute myocardial infarction within 24 hours after COVID-19 vaccination: is Kounis syndrome the culprit: https://pubmed.ncbi.nlm.nih.gov/34702550/\n\u2022 Deaths associated with the recently launched SARS-CoV-2 vaccination (Comirnaty\u00ae): https://pubmed.ncbi.nlm.nih.gov/33895650/\n\u2022 A case of acute encephalopathy and non-ST-segment elevation myocardial infarction after vaccination with mRNA-1273: possible adverse effect: https://pubmed.ncbi.nlm.nih.gov/34703815/\n\u2022 Vasculitis and bursitis in [ 18 F] FDG-PET/CT after COVID-19 mRNA vaccine: post hoc ergo propter hoc?; https://pubmed.ncbi.nlm.nih.gov/34495381/.\n\u2022 Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and crescentic Pauci-Inmune glomerulonephritis after vaccination with Pfizer-BioNTech COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34659268/\n\u2022 Reactivation of IgA vasculitis after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34848431/\n\u2022 A rare case of Henoch-Sch\u00f6nlein purpura after a case report of COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34518812/\n\u2022 IgA vasculitis following COVID-19 vaccination in an adult: https://pubmed.ncbi.nlm.nih.gov/34779011/\n\u2022 Clinical and histopathologic spectrum of delayed adverse skin reactions after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34292611/.\n\u2022 First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: case report: https://pubmed.ncbi.nlm.nih.gov/34530771/.\n\u2022 Nephrotic syndrome and vasculitis after SARS-CoV-2 vaccine: true association or circumstantial: https://pubmed.ncbi.nlm.nih.gov/34245294/.\n\u2022 Occurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34599716/.\n\u2022 Asymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophils: https://pubmed.ncbi.nlm.nih.gov/34115904/.\n\u2022 Henoch-Sch\u00f6nlein purpura following the first dose of COVID-19 viral vector vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34696186/.\n\u2022 Acute retinal necrosis due to varicella zoster virus reactivation after vaccination with BNT162b2 COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34851795/.\n\u2022 A case of generalized Sweet\u2019s syndrome with vasculitis triggered by recent vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34849386/\n\u2022 Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria on cyclosporine treatment \u2013 A report of 3 cases: https://pubmed.ncbi.nlm.nih.gov/34510694/\n\u2022 Outbreaks of mixed cryoglobulinemia vasculitis after vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34819272/\n\u2022 Cutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34337124/\n\u2022 Case of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019: https://pubmed.ncbi.nlm.nih.gov/34535924/\n\u2022 Hypermetabolic lymphadenopathy after administration of BNT162b2 mRNA vaccine Covid-19: incidence assessed by [ 18 F] FDG PET-CT and relevance for study interpretation: https://pubmed.ncbi.nlm.nih.gov/33774684/\n\u2022 Evolution of bilateral hypermetabolic axillary hypermetabolic lymphadenopathy on FDG PET/CT after 2-dose COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34735411/\n\u2022 Lymphadenopathy associated with COVID-19 vaccination on FDG PET/CT: distinguishing features in adenovirus-vectored vaccine: https://pubmed.ncbi.nlm.nih.gov/34115709/.\n\u2022 COVID-19 vaccination-induced lymphadenopathy in a specialized breast imaging clinic in Israel: analysis of 163 cases: https://pubmed.ncbi.nlm.nih.gov/34257025/.\n\u2022 Regional lymphadenopathy after COVID-19 vaccination: review of the literature and considerations for patient management in breast cancer care: https://pubmed.ncbi.nlm.nih.gov/34731748/\n\u2022 Subclinical axillary lymphadenopathy associated with COVID-19 vaccination on screening mammography: https://pubmed.ncbi.nlm.nih.gov/34906409/\n\u2022 Adverse events of COVID injection that may occur in children.Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021: https://pubmed.ncbi.nlm.nih.gov/33706861/\n\u2022 Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/\n\u2022 Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding: https://pubmed.ncbi.nlm.nih.gov/33661328/\n\u2022 Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/\n\u2022 Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women: https://pubmed.ncbi.nlm.nih.gov/33624520/\n\u2022 Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database: https://pubmed.ncbi.nlm.nih.gov/34835256/\n\u2022 Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: https://pubmed.ncbi.nlm.nih.gov/33713605/\n\u2022 Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up: https://pubmed.ncbi.nlm.nih.gov/34298342/\n\u2022 A systematic review of cases of CNS demyelination following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34839149/\n\u2022 Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: https://pubmed.ncbi.nlm.nih.gov/33685772/\n\u2022 COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT: https://pubmed.ncbi.nlm.nih.gov/34719892/\n\u2022 Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/.\n\u2022 Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: https://pubmed.ncbi.nlm.nih.gov/34526175/\n\u2022 Lymphadenopathy associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33786231/\n\u2022 Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33625301/.\n\u2022 Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma: https://pubmed.ncbi.nlm.nih.gov/34825530/.\n\u2022 Acute-onset supraclavicular lymphadenopathy coincident with intramuscular mRNA vaccination against COVID-19 may be related to the injection technique of the vaccine, Spain, January and February 2021: https://pubmed.ncbi.nlm.nih.gov/33706861/\n\u2022 Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up by ultrasonography: https://pubmed.ncbi.nlm.nih.gov/34116295/\n\u2022 Oxford-AstraZeneca COVID-19 vaccination induced lymphadenopathy on [18F] choline PET / CT, not just an FDG finding: https://pubmed.ncbi.nlm.nih.gov/33661328/\n\u2022 Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/\n\u2022 Axillary adenopathy associated with COVID-19 vaccination: imaging findings and follow-up recommendations in 23 women: https://pubmed.ncbi.nlm.nih.gov/33624520/\n\u2022 Thrombotic adverse events reported for Moderna, Pfizer, and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the EudraVigilance database: https://pubmed.ncbi.nlm.nih.gov/34835256/\n\u2022 Unilateral lymphadenopathy after COVID-19 vaccination: a practical management plan for radiologists of all specialties: https://pubmed.ncbi.nlm.nih.gov/33713605/\n\u2022 Unilateral axillary adenopathy in the setting of COVID-19 vaccination: follow-up: https://pubmed.ncbi.nlm.nih.gov/34298342/\n\u2022 A systematic review of cases of CNS demyelination following COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34839149/\n\u2022 Supraclavicular lymphadenopathy after COVID-19 vaccination: an increasing presentation in the two-week wait neck lump clinic: https://pubmed.ncbi.nlm.nih.gov/33685772/\n\u2022 COVID-19 vaccine-related axillary and cervical lymphadenopathy in patients with current or previous breast cancer and other malignancies: cross-sectional imaging findings on MRI, CT and PET-CT: https://pubmed.ncbi.nlm.nih.gov/34719892/\n\u2022 Incidence of axillary adenopathy on breast imaging after vaccination with COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/.\n\u2022 Cervical lymphadenopathy after coronavirus disease vaccination 2019: clinical features and implications for head and neck cancer services: https://pubmed.ncbi.nlm.nih.gov/34526175/\n\u2022 Lymphadenopathy associated with the COVID-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/33786231/\n\u2022 Evolution of lymphadenopathy on PET/MRI after COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/33625301/.\n\u2022 Axillary lymphadenopathy in patients with recent Covid-19 vaccination: a new diagnostic dilemma: https://pubmed.ncbi.nlm.nih.gov/34825530/.\n\u2022 Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, P. R., Klein, K., . . . Danielides, S. (2021). Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol, 340, 119-121. doi:10.1016/j.ijcard.2021.08.018. https://www.ncbi.nlm.nih.gov/pubmed/34416319\n\u2022 Aye, Y. N., Mai, A. S., Zhang, A., Lim, O. Z. H., Lin, N., Ng, C. H., . . . Chew, N. W. S. (2021). Acute Myocardial Infarction and Myocarditis following COVID-19 Vaccination. QJM. doi:10.1093/qjmed/hcab252. https://www.ncbi.nlm.nih.gov/pubmed/34586408\n\u2022 Azir, M., Inman, B., Webb, J., & Tannenbaum, L. (2021). STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine. J Emerg Med, 61(6), e129-e132. doi:10.1016/j.jemermed.2021.09.017. https://www.ncbi.nlm.nih.gov/pubmed/34756746\n\u2022 Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R., . . . Balicer, R. D. (2021). Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med, 385(12), 1078-1090. doi:10.1056/NEJMoa2110475. https://www.ncbi.nlm.nih.gov/pubmed/34432976\n\u2022 Bhandari, M., Pradhan, A., Vishwakarma, P., & Sethi, R. (2021). Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol, 13(10), 556-565. doi:10.4330/wjc.v13.i10.556. https://www.ncbi.nlm.nih.gov/pubmed/34754400\n\u2022 Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J., & Heidecke, H. (2021). Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome? Vaccines (Basel), 9(11). doi:10.3390/vaccines9111353. https://www.ncbi.nlm.nih.gov/pubmed/34835284\n\u2022 Calcaterra, G., Bassareo, P. P., Barilla, F., Romeo, F., & Mehta, J. L. (2022). Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines. J Cardiovasc Med (Hagerstown), 23(2), 71-74. doi:10.2459/JCM.0000000000001232. https://www.ncbi.nlm.nih.gov/pubmed/34366403\n\u2022 Calcaterra, G., Mehta, J. L., de Gregorio, C., Butera, G., Neroni, P., Fanos, V., & Bassareo, P. P. (2021). COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatr Rep, 13(3), 530-533. doi:10.3390/pediatric13030061. https://www.ncbi.nlm.nih.gov/pubmed/34564344\n\u2022 Chai, Q., Nygaard, U., Schmidt, R. C., Zaremba, T., Moller, A. M., & Thorvig, C. M. (2022). Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr, 111(1), 125-127. doi:10.1111/apa.16141. https://www.ncbi.nlm.nih.gov/pubmed/34617315\n\u2022 Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C., . . . Yilmaz, A. (2021). Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? Clin Res Cardiol, 110(11), 1850-1854. doi:10.1007/s00392-021-01916-w. https://www.ncbi.nlm.nih.gov/pubmed/34333695\n\u2022 Chang, J. C., & Hawley, H. B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina (Kaunas), 57(11). doi:10.3390/medicina57111163. https://www.ncbi.nlm.nih.gov/pubmed/34833382\n\u2022 Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N., & White, C. (2021). Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. doi:10.2214/AJR.21.26853. https://www.ncbi.nlm.nih.gov/pubmed/34704459\n\u2022 Choi, S., Lee, S., Seo, J. W., Kim, M. J., Jeon, Y. H., Park, J. H., . . . Yeo, N. S. (2021). Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J Korean Med Sci, 36(40), e286. doi:10.3346/jkms.2021.36.e286. https://www.ncbi.nlm.nih.gov/pubmed/34664804\n\u2022 Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, T. S., Nair, G., Robblee, J., . . . Liu, P. P. (2021). Features of Inflammatory Heart Reactions Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. doi:10.1002/cpt.2499. https://www.ncbi.nlm.nih.gov/pubmed/34860360\n\u2022 Chua, G. T., Kwan, M. Y. W., Chui, C. S. L., Smith, R. D., Cheung, E. C., Tian, T., . . . Ip, P. (2021). Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. doi:10.1093/cid/ciab989. https://www.ncbi.nlm.nih.gov/pubmed/34849657\n\u2022 Clarke, R., & Ioannou, A. (2021). Should T2 mapping be used in cases of recurrent myocarditis to differentiate between the acute inflammation and chronic scar? J Pediatr. doi:10.1016/j.jpeds.2021.12.026. https://www.ncbi.nlm.nih.gov/pubmed/34933012\n\u2022 Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A., . . . Bruno, R. (2021). COVID vaccination and asthma exacerbation: might there be a link? Int J Infect Dis, 112, 243-246. doi:10.1016/j.ijid.2021.09.026. https://www.ncbi.nlm.nih.gov/pubmed/34547487\n\u2022 Das, B. B., Kohli, U., Ramachandran, P., Nguyen, H. H., Greil, G., Hussain, T., . . . Khan, D. (2021). Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr, 238, 26-32 e21. doi:10.1016/j.jpeds.2021.07.044. https://www.ncbi.nlm.nih.gov/pubmed/34339728\n\u2022 Das, B. B., Moskowitz, W. B., Taylor, M. B., & Palmer, A. (2021). Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far? Children (Basel), 8(7). doi:10.3390/children8070607. https://www.ncbi.nlm.nih.gov/pubmed/34356586\n\u2022 Deb, A., Abdelmalek, J., Iwuji, K., & Nugent, K. (2021). Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. J Prim Care Community Health, 12, 21501327211029230. doi:10.1177/21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34219532\n\u2022 Dickey, J. B., Albert, E., Badr, M., Laraja, K. M., Sena, L. M., Gerson, D. S., . . . Aurigemma, G. P. (2021). A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging, 14(9), 1862-1863. doi:10.1016/j.jcmg.2021.06.003. https://www.ncbi.nlm.nih.gov/pubmed/34246585\n\u2022 Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, M. N., & Maritsi, D. N. (2021). Safety and tolerability of the COVID-19 mRNA-vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF-inhibitors. Arthritis Rheumatol. doi:10.1002/art.41977. https://www.ncbi.nlm.nih.gov/pubmed/34492161\n\u2022 Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M., & Maritsi, D. (2021). Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Ann Rheum Dis. doi:10.1136/annrheumdis-2021-221607. https://www.ncbi.nlm.nih.gov/pubmed/34844930\n\u2022 Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Huttinger, S., Sood, N., Pickuth, D., & Kindermann, M. (2021). Biopsy-proven lymphocytic myocarditis following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res Cardiol, 110(11), 1855-1859. doi:10.1007/s00392-021-01936-6. https://www.ncbi.nlm.nih.gov/pubmed/34487236\n\u2022 El Sahly, H. M., Baden, L. R., Essink, B., Doblecki-Lewis, S., Martin, J. M., Anderson, E. J., . . . Group, C. S. (2021). Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med, 385(19), 1774-1785. doi:10.1056/NEJMoa2113017. https://www.ncbi.nlm.nih.gov/pubmed/34551225\n\u2022 Facetti, S., Giraldi, M., Vecchi, A. L., Rogiani, S., & Nassiacos, D. (2021). [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital Cardiol (Rome), 22(11), 891-893. doi:10.1714/3689.36746. https://www.ncbi.nlm.nih.gov/pubmed/34709227\n\u2022 Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, S. A., Sullman, M. J. M., Shekarriz-Foumani, R., . . . Safiri, S. (2021). Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol, e2318. doi:10.1002/rmv.2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468\n\u2022 Fazolo, T., Lima, K., Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., . . . Bonorino, C. (2021). Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nat Commun, 12(1), 6844. doi:10.1038/s41467-021-27120-y. https://www.ncbi.nlm.nih.gov/pubmed/34824230\n\u2022 Fikenzer, S., & Laufs, U. (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. Advance online publication. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol, 110(8), 1352. doi:10.1007/s00392-021-01896-x. https://www.ncbi.nlm.nih.gov/pubmed/34170372\n\u2022 Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S., . . . Montastruc, F. (2021). Myocarditis and Pericarditis in Adolescents after First and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes. doi:10.1093/ehjqcco/qcab090. https://www.ncbi.nlm.nih.gov/pubmed/34849667\n\u2022 Forgacs, D., Jang, H., Abreu, R. B., Hanley, H. B., Gattiker, J. L., Jefferson, A. M., & Ross, T. M. (2021). SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans. Front Immunol, 12, 728021. doi:10.3389/fimmu.2021.728021. https://www.ncbi.nlm.nih.gov/pubmed/34646267\n\u2022 Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., . . . Elkayam, O. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis, 80(10), 1330-1338. doi:10.1136/annrheumdis-2021-220647. https://www.ncbi.nlm.nih.gov/pubmed/34127481\n\u2022 Galindo, R., Chow, H., & Rongkavilit, C. (2021). COVID-19 in Children: Clinical Manifestations and Pharmacologic Interventions Including Vaccine Trials. Pediatr Clin North Am, 68(5), 961-976. doi:10.1016/j.pcl.2021.05.004. https://www.ncbi.nlm.nih.gov/pubmed/34538306\n\u2022 Gargano, J. W., Wallace, M., Hadler, S. C., Langley, G., Su, J. R., Oster, M. E., . . . Oliver, S. E. (2021). Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices \u2013 United States, June 2021. MMWR Morb Mortal Wkly Rep, 70(27), 977-982. doi:10.15585/mmwr.mm7027e2. https://www.ncbi.nlm.nih.gov/pubmed/34237049\n\u2022 Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021). Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel), 9(1). doi:10.3390/vaccines9010019. https://www.ncbi.nlm.nih.gov/pubmed/33406694\n\u2022 Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., . . . Golden, D. B. K. (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract, 9(10), 3546-3567. doi:10.1016/j.jaip.2021.06.006. https://www.ncbi.nlm.nih.gov/pubmed/34153517\n\u2022 Haaf, P., Kuster, G. M., Mueller, C., Berger, C. T., Monney, P., Burger, P., . . . Tanner, F. C. (2021). The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly, 151, w30087. doi:10.4414/smw.2021.w30087. https://www.ncbi.nlm.nih.gov/pubmed/34668687\n\u2022 Hasnie, A. A., Hasnie, U. A., Patel, N., Aziz, M. U., Xie, M., Lloyd, S. G., & Prabhu, S. D. (2021). Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord, 21(1), 375. doi:10.1186/s12872-021-02183-3. https://www.ncbi.nlm.nih.gov/pubmed/34348657\n\u2022 Hippisley-Cox, J., Patone, M., Mei, X. W., Saatci, D., Dixon, S., Khunti, K., . . . Coupland, C. A. C. (2021). Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ, 374, n1931. doi:10.1136/bmj.n1931. https://www.ncbi.nlm.nih.gov/pubmed/34446426\n\u2022 Ho, J. S., Sia, C. H., Ngiam, J. N., Loh, P. H., Chew, N. W., Kong, W. K., & Poh, K. K. (2021). A review of COVID-19 vaccination and the reported cardiac manifestations. Singapore Med J. doi:10.11622/smedj.2021210. https://www.ncbi.nlm.nih.gov/pubmed/34808708\n\u2022 Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N., & Sato, D. (2021). Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report. Drug Saf, 44(11), 1209-1214. doi:10.1007/s40264-021-01104-9. https://www.ncbi.nlm.nih.gov/pubmed/34347278\n\u2022 In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. (2021). Med Lett Drugs Ther, 63(1629), e9. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/pubmed/3454412\n\u2022 Ioannou, A. (2021a). Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM. doi:10.1093/qjmed/hcab231. https://www.ncbi.nlm.nih.gov/pubmed/34463755\n\u2022 Ioannou, A. (2021b). T2 mapping should be utilised in cases of suspected myocarditis to confirm an acute inflammatory process. QJM. doi:10.1093/qjmed/hcab326. https://www.ncbi.nlm.nih.gov/pubmed/34931681\n\u2022 Istampoulouoglou, I., Dimitriou, G., Spani, S., Christ, A., Zimmermanns, B., Koechlin, S., . . . Leuppi-Taegtmeyer, A. B. (2021). Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract, 2021(3), e202118. doi:10.21542/gcsp.2021.18. https://www.ncbi.nlm.nih.gov/pubmed/34805376\n\u2022 Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S., . . . La Scola, B. (2021). High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2. Viruses, 13(11). doi:10.3390/v13112177. https://www.ncbi.nlm.nih.gov/pubmed/34834983\n\u2022 Jhaveri, R., Adler-Shohet, F. C., Blyth, C. C., Chiotos, K., Gerber, J. S., Green, M., . . . Zaoutis, T. (2021). Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc, 10(10), 937-939. doi:10.1093/jpids/piab061. https://www.ncbi.nlm.nih.gov/pubmed/34270752\n\u2022 Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N., & Node, K. (2021). Young Male With Myocarditis Following mRNA-1273 Vaccination Against Coronavirus Disease-2019 (COVID-19). Circ J. doi:10.1253/circj.CJ-21-0818. https://www.ncbi.nlm.nih.gov/pubmed/34744118\n\u2022 Kim, H. W., Jenista, E. R., Wendell, D. C., Azevedo, C. F., Campbell, M. J., Darty, S. N., . . . Kim, R. J. (2021). Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiol, 6(10), 1196-1201. doi:10.1001/jamacardio.2021.2828. https://www.ncbi.nlm.nih.gov/pubmed/34185046\n\u2022 Kim, I. C., Kim, H., Lee, H. J., Kim, J. Y., & Kim, J. Y. (2021). Cardiac Imaging of Acute Myocarditis Following COVID-19 mRNA Vaccination. J Korean Med Sci, 36(32), e229. doi:10.3346/jkms.2021.36.e229. https://www.ncbi.nlm.nih.gov/pubmed/34402228\n\u2022 King, W. W., Petersen, M. R., Matar, R. M., Budweg, J. B., Cuervo Pardo, L., & Petersen, J. W. (2021). Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus, 8, 100042. doi:10.1016/j.ahjo.2021.100042. https://www.ncbi.nlm.nih.gov/pubmed/34396358\n\u2022 Klimek, L., Bergmann, K. C., Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K., . . . Worm, M. (2021). Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and OGAI. Allergo J Int, 1-17. doi:10.1007/s40629-021-00165-7. https://www.ncbi.nlm.nih.gov/pubmed/33898162\n\u2022 Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C., . . . Worm, M. (2021). Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA). Allergo J Int, 30(2), 51-55. doi:10.1007/s40629-020-00160-4. https://www.ncbi.nlm.nih.gov/pubmed/33643776\n\u2022 Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021a). Erratum to \u201cWhy are we vaccinating children against COVID-19?\u201d [Toxicol. Rep. 8C (2021) 1665-1684 / 1193]. Toxicol Rep, 8, 1981. doi:10.1016/j.toxrep.2021.10.003. https://www.ncbi.nlm.nih.gov/pubmed/34642628\n\u2022 Kostoff, R. N., Calina, D., Kanduc, D., Briggs, M. B., Vlachoyiannopoulos, P., Svistunov, A. A., & Tsatsakis, A. (2021b). Why are we vaccinating children against COVID-19? Toxicol Rep, 8, 1665-1684. doi:10.1016/j.toxrep.2021.08.010. https://www.ncbi.nlm.nih.gov/pubmed/34540594\n\u2022 Kremsner, P. G., Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, J. J., . . . Group, C.-N.-S. (2021). Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr, 133(17-18), 931-941. doi:10.1007/s00508-021-01922-y. https://www.ncbi.nlm.nih.gov/pubmed/34378087\n\u2022 Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., . . . Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med, 27(8), 1379-1384. doi:10.1038/s41591-021-01413-7. https://www.ncbi.nlm.nih.gov/pubmed/34127854\n\u2022 Kwan, M. Y. W., Chua, G. T., Chow, C. B., Tsao, S. S. L., To, K. K. W., Yuen, K. Y., . . . Ip, P. (2021). mRNA COVID vaccine and myocarditis in adolescents. Hong Kong Med J, 27(5), 326-327. doi:10.12809/hkmj215120. https://www.ncbi.nlm.nih.gov/pubmed/34393110\n\u2022 Lee, E., Chew, N. W. S., Ng, P., & Yeo, T. J. (2021). Reply to \u201cLetter to the editor: Myocarditis should be considered in those with a troponin rise and unobstructed coronary arteries following PfizerBioNTech COVID-19 vaccination\u201d. QJM. doi:10.1093/qjmed/hcab232. https://www.ncbi.nlm.nih.gov/pubmed/34463770\n\u2022 Lee, E. J., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., . . . Bussel, J. B. (2021). Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol, 96(5), 534-537. doi:10.1002/ajh.26132. https://www.ncbi.nlm.nih.gov/pubmed/33606296\n\u2022 Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H., . . . Zhu, F. (2021). Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study. Nat Med, 27(6), 1062-1070. doi:10.1038/s41591-021-01330-9. https://www.ncbi.nlm.nih.gov/pubmed/33888900\n\u2022 Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X., & Lu, Z. K. (2021). Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. J Pers Med, 11(11). doi:10.3390/jpm11111106. https://www.ncbi.nlm.nih.gov/pubmed/34834458\n\u2022 Lim, Y., Kim, M. C., Kim, K. H., Jeong, I. S., Cho, Y. S., Choi, Y. D., & Lee, J. E. (2021). Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med, 8, 758996. doi:10.3389/fcvm.2021.758996. https://www.ncbi.nlm.nih.gov/pubmed/34778411\n\u2022 Long, S. S. (2021). Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. J Pediatr, 238, 5. doi:10.1016/j.jpeds.2021.07.057. https://www.ncbi.nlm.nih.gov/pubmed/34332972\n\u2022 Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B., . . . McDonald, M. (2021). Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers. Can J Cardiol, 37(10), 1629-1634. doi:10.1016/j.cjca.2021.08.001. https://www.ncbi.nlm.nih.gov/pubmed/34375696\n\u2022 Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, D. O., . . . Eberhardt, C. S. (2021). Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis. doi:10.1093/cid/ciab954. https://www.ncbi.nlm.nih.gov/pubmed/34791081\n\u2022 Mangat, C., & Milosavljevic, N. (2021). BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age. Case Rep Pediatr, 2021, 6901131. doi:10.1155/2021/6901131. https://www.ncbi.nlm.nih.gov/pubmed/34676123\n\u2022 Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A., . . . Alexander, S. (2021). Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase. Pediatr Blood Cancer, 68(11), e29295. doi:10.1002/pbc.29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511\n\u2022 Martins-Filho, P. R., Quintans-Junior, L. J., de Souza Araujo, A. A., Sposato, K. B., Souza Tavares, C. S., Gurgel, R. Q., . . . Santos, V. S. (2021). Socio-economic inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide register-based study. Public Health, 190, 4-6. doi:10.1016/j.puhe.2020.11.005. https://www.ncbi.nlm.nih.gov/pubmed/33316478\n\u2022 Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, E. J., Nadir, E., . . . Alroy-Preis, S. (2021). Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. N Engl J Med, 385(23), 2140-2149. doi:10.1056/NEJMoa2109730. https://www.ncbi.nlm.nih.gov/pubmed/34614328\n\u2022 Minocha, P. K., Better, D., Singh, R. K., & Hoque, T. (2021). Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent. J Pediatr, 238, 321-323. doi:10.1016/j.jpeds.2021.06.035. https://www.ncbi.nlm.nih.gov/pubmed/34166671\n\u2022 Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C., & Malley, R. (2021). Analysis of Staphylococcus aureus Transcriptome in Pediatric Soft Tissue Abscesses and Comparison to Murine Infections. Infect Immun, 89(4). doi:10.1128/IAI.00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560\n\u2022 Mohamed, L., Madsen, A. M. R., Schaltz-Buchholzer, F., Ostenfeld, A., Netea, M. G., Benn, C. S., & Kofoed, P. E. (2021). Reactivation of BCG vaccination scars after vaccination with mRNA-Covid-vaccines: two case reports. BMC Infect Dis, 21(1), 1264. doi:10.1186/s12879-021-06949-0. https://www.ncbi.nlm.nih.gov/pubmed/34930152\n\u2022 Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L., . . . Cooper, L. T., Jr. (2021). Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol, 6(10), 1202-1206. doi:10.1001/jamacardio.2021.2833. https://www.ncbi.nlm.nih.gov/pubmed/34185045\n\u2022 Ntouros, P. A., Vlachogiannis, N. I., Pappa, M., Nezos, A., Mavragani, C. P., Tektonidou, M. G., . . . Sfikakis, P. P. (2021). Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus. Clin Immunol, 229, 108765. doi:10.1016/j.clim.2021.108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859\n\u2022 Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, L. S., Hartling, U. B., . . . Stensballe, L. G. (2022). Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J, 41(1), e25-e28. doi:10.1097/INF.0000000000003389. https://www.ncbi.nlm.nih.gov/pubmed/34889875\n\u2022 Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S., . . . Hofmann, M. (2021). Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 597(7875), 268-273. doi:10.1038/s41586-021-03841-4. https://www.ncbi.nlm.nih.gov/pubmed/34320609\n\u2022 Park, H., Yun, K. W., Kim, K. R., Song, S. H., Ahn, B., Kim, D. R., . . . Kim, Y. J. (2021). Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study. J Korean Med Sci, 36(32), e232. doi:10.3346/jkms.2021.36.e232. https://www.ncbi.nlm.nih.gov/pubmed/34402230\n\u2022 Park, J., Brekke, D. R., & Bratincsak, A. (2021). Self-limited myocarditis presenting with chest pain and ST segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine. Cardiol Young, 1-4. doi:10.1017/S1047951121002547. https://www.ncbi.nlm.nih.gov/pubmed/34180390\n\u2022 Patel, Y. R., Louis, D. W., Atalay, M., Agarwal, S., & Shah, N. R. (2021). Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series. J Cardiovasc Magn Reson, 23(1), 101. doi:10.1186/s12968-021-00795-4. https://www.ncbi.nlm.nih.gov/pubmed/34496880\n\u2022 Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., . . . Hippisley-Cox, J. (2021). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. doi:10.1038/s41591-021-01630-0. https://www.ncbi.nlm.nih.gov/pubmed/34907393\n\u2022 Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Acute myocarditis following Comirnaty vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep, 16(11), 3321-3325. doi:10.1016/j.radcr.2021.07.082. https://www.ncbi.nlm.nih.gov/pubmed/34367386\n\u2022 Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, A. G., . . . Peruzzi, M. (2021). A snapshot global survey on side effects of COVID-19 vaccines among healthcare professionals and armed forces with a focus on headache. Panminerva Med, 63(3), 324-331. doi:10.23736/S0031-0808.21.04435-9. https://www.ncbi.nlm.nih.gov/pubmed/34738774\n\u2022 Pinana, J. L., Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A., . . . Cell Therapy, G. (2022). SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group. Am J Hematol, 97(1), 30-42. doi:10.1002/ajh.26385. https://www.ncbi.nlm.nih.gov/pubmed/34695229\n\u2022 Revon-Riviere, G., Ninove, L., Min, V., Rome, A., Coze, C., Verschuur, A., . . . Andre, N. (2021). The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience. Eur J Cancer, 154, 30-34. doi:10.1016/j.ejca.2021.06.002. https://www.ncbi.nlm.nih.gov/pubmed/34233234\n\u2022 Sanchez Tijmes, F., Thavendiranathan, P., Udell, J. A., Seidman, M. A., & Hanneman, K. (2021). Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination. Radiol Cardiothorac Imaging, 3(6), e210252. doi:10.1148/ryct.210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954\n\u2022 Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S., & Portman, M. A. (2021). Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr, 238, 317-320. doi:10.1016/j.jpeds.2021.06.083. https://www.ncbi.nlm.nih.gov/pubmed/34228985\n\u2022 Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, H. U., Kuhnen, C., . . . Schmeling, A. (2021). Postmortem investigation of fatalities following vaccination with COVID-19 vaccines. Int J Legal Med, 135(6), 2335-2345. doi:10.1007/s00414-021-02706-9. https://www.ncbi.nlm.nih.gov/pubmed/34591186\n\u2022 Schramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U., . . . Gummert, J. (2021). Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients. Clin Res Cardiol, 110(8), 1142-1149. doi:10.1007/s00392-021-01880-5. https://www.ncbi.nlm.nih.gov/pubmed/34241676\n\u2022 Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Autopsy Findings and Causality Relationship between Death and COVID-19 Vaccination: A Systematic Review. J Clin Med, 10(24). doi:10.3390/jcm10245876. https://www.ncbi.nlm.nih.gov/pubmed/34945172\n\u2022 Sharif, N., Alzahrani, K. J., Ahmed, S. N., & Dey, S. K. (2021). Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol, 12, 714170. doi:10.3389/fimmu.2021.714170. https://www.ncbi.nlm.nih.gov/pubmed/34707602\n\u2022 Shazley, O., & Alshazley, M. (2021). A COVID-Positive 52-Year-Old Man Presented With Venous Thromboembolism and Disseminated Intravascular Coagulation Following Johnson & Johnson Vaccination: A Case-Study. Cureus, 13(7), e16383. doi:10.7759/cureus.16383. https://www.ncbi.nlm.nih.gov/pubmed/34408937\n\u2022 Simone, A., Herald, J., Chen, A., Gulati, N., Shen, A. Y., Lewin, B., & Lee, M. S. (2021). Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med, 181(12), 1668-1670. doi:10.1001/jamainternmed.2021.5511. https://www.ncbi.nlm.nih.gov/pubmed/34605853\n\u2022 Singer, M. E., Taub, I. B., & Kaelber, D. C. (2021). Risk of Myocarditis from COVID-19 Infection in People Under Age 20: A Population-Based Analysis. medRxiv. doi:10.1101/2021.07.23.21260998. https://www.ncbi.nlm.nih.gov/pubmed/34341797\n\u2022 Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M., . . . Fraser, L. K. (2021). Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year. Nat Med. doi:10.1038/s41591-021-01578-1. https://www.ncbi.nlm.nih.gov/pubmed/34764489\n\u2022 Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I., . . . Bilavsky, E. (2021). Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J, 40(10), e360-e363. doi:10.1097/INF.0000000000003235. https://www.ncbi.nlm.nih.gov/pubmed/34077949\n\u2022 Spinner, J. A., Julien, C. L., Olayinka, L., Dreyer, W. J., Bocchini, C. E., Munoz, F. M., & Devaraj, S. (2021). SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant. doi:10.1016/j.healun.2021.11.001. https://www.ncbi.nlm.nih.gov/pubmed/34911654\n\u2022 Sulemankhil, I., Abdelrahman, M., & Negi, S. I. (2021). Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2021.08.012. https://www.ncbi.nlm.nih.gov/pubmed/34420869\n\u2022 Tailor, P. D., Feighery, A. M., El-Sabawi, B., & Prasad, A. (2021). Case report: acute myocarditis following the second dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep, 5(8), ytab319. doi:10.1093/ehjcr/ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306\n\u2022 Team, C. C.-R., Food, & Drug, A. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine \u2013 United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep, 70(2), 46-51. doi:10.15585/mmwr.mm7002e1. https://www.ncbi.nlm.nih.gov/pubmed/33444297\n\u2022 Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H., Yoon, S. K., Meece, J., . . . Gaglani, M. (2021). Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med, 385(4), 320-329. doi:10.1056/NEJMoa2107058. https://www.ncbi.nlm.nih.gov/pubmed/34192428\n\u2022 Truong, D. T., Dionne, A., Muniz, J. C., McHugh, K. E., Portman, M. A., Lambert, L. M., . . . Newburger, J. W. (2021). Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults. Circulation. doi:10.1161/CIRCULATIONAHA.121.056583. https://www.ncbi.nlm.nih.gov/pubmed/34865500\n\u2022 Umei, T. C., Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S., & Fukuda, K. (2021). Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent. CJC Open. doi:10.1016/j.cjco.2021.12.002. https://www.ncbi.nlm.nih.gov/pubmed/34904134\n\u2022 Vidula, M. K., Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, V. A., & Han, Y. (2021). Myocarditis and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines. Cureus, 13(6), e15576. doi:10.7759/cureus.15576. https://www.ncbi.nlm.nih.gov/pubmed/34277198\n\u2022 Warren, C. M., Snow, T. T., Lee, A. S., Shah, M. M., Heider, A., Blomkalns, A., . . . Nadeau, K. C. (2021). Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open, 4(9), e2125524. doi:10.1001/jamanetworkopen.2021.25524. https://www.ncbi.nlm.nih.gov/pubmed/34533570\n\u2022 Watkins, K., Griffin, G., Septaric, K., & Simon, E. L. (2021). Myocarditis after BNT162b2 vaccination in a healthy male. Am J Emerg Med, 50, 815 e811-815 e812. doi:10.1016/j.ajem.2021.06.051. https://www.ncbi.nlm.nih.gov/pubmed/34229940\n\u2022 Weitzman, E. R., Sherman, A. C., & Levy, O. (2021). SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Front Public Health, 9, 695807. doi:10.3389/fpubh.2021.695807. https://www.ncbi.nlm.nih.gov/pubmed/34336774\n\u2022 Welsh, K. J., Baumblatt, J., Chege, W., Goud, R., & Nair, N. (2021). Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine, 39(25), 3329-3332. doi:10.1016/j.vaccine.2021.04.054. https://www.ncbi.nlm.nih.gov/pubmed/34006408\n\u2022 Zimmermann, P., & Curtis, N. (2020). Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. doi:10.1136/archdischild-2020-320338. https://www.ncbi.nlm.nih.gov/pubmed/33262177\n\nNote to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.", "opengraph": {"locale": "en_US", "type": "article", "title": "COVID-19 Vaccines: Proof of Lethality. Over One Thousand Scientific Studies - Global Research", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow us on Instagram at @globalresearch_crg. First published by Global Research on January 21, 2022 Since the publication \u2026", "url": "https://www.globalresearch.ca/covid-19-vaccines-scientific-proof-lethality/5767711", "site_name": "Global Research", "article:tag": "United Kingdom", "article:section": "English", "article:published_time": "2023-04-15T15:02:30+00:00", "article:modified_time": "2023-04-15T19:53:20+00:00", "updated_time": "2023-04-15T19:53:20+00:00", "image": "https://www.globalresearch.ca/wp-content/uploads/2021/08/RFK-Jr-journalists-report-truth-Covid-vaccines-feature-800x417.jpg", "image:secure_url": "https://www.globalresearch.ca/wp-content/uploads/2021/08/RFK-Jr-journalists-report-truth-Covid-vaccines-feature-800x417.jpg", "image:width": "800", "image:height": "417"}, "tags": ["Europe", "Media Disinformation", "Science and Medicine"], "tweets": [], "movies": [], "links": ["https://lp.constantcontactpages.com/su/IJiNQuW?EMAIL=&go.x=0&go.y=0&go=GO", "https://www.instagram.com/globalresearch_crg/", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/", "https://www.sciencedirect.com/science/article/pii/S1052305721003414", "https://pubmed.ncbi.nlm.nih.gov/33928772/", "https://www.sciencedirect.com/science/article/pii/S2666602221000409", "https://www.sciencedirect.com/science/article/pii/S2213333X21003929", "https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988", "https://pubmed.ncbi.nlm.nih.gov/33929487/", "https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/", "https://pubmed.ncbi.nlm.nih.gov/33871350/", "https://www.sciencedirect.com/science/article/pii/S0022510X21003014", "https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381", "https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505", "https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904", "https://www.sciencedirect.com/science/article/pii/S1665268121000557", "https://www.sciencedirect.com/science/article/pii/S1050173821000967", "https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160", "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext", "https://www.nejm.org/doi/full/10.1056/nejme2106315", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601", "https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article", "https://pubmed.ncbi.nlm.nih.gov/34374740/", "https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article", "https://haematologica.org/article/view/haematol.2021.279075", "https://www.sciencedirect.com/science/article/pii/S0264410X21005247", "https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478", "https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005", "https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895", "https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315", "https://www.sciencedirect.com/science/article/pii/S0896841121000937", "https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098", "https://www.sciencedirect.com/science/article/pii/S0953620521002363", "https://www.sciencedirect.com/science/article/pii/S0828282X21006243", "https://www.sciencedirect.com/science/article/pii/S2666572721000389", "https://www.sciencedirect.com/science/article/pii/S0196064421003425", "https://www.sciencedirect.com/science/article/pii/S1443950621011562", "https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706", "https://www.sciencedirect.com/science/article/pii/S0006497121009411", "https://www.sciencedirect.com/science/article/pii/S2589936821000256", "https://www.sciencedirect.com/science/article/pii/S1871402121002046", "https://www.sciencedirect.com/science/article/pii/S0049384821004369", "https://www.sciencedirect.com/science/article/pii/S0735109721051949", "https://www.sciencedirect.com/science/article/pii/S0735675721005714", "https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X", "https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963", "https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ", "https://www.sciencedirect.com/science/article/pii/S0953620521002314", "https://www.sciencedirect.com/science/article/pii/S0213485321000839", "https://pubmed.ncbi.nlm.nih.gov/33918932/", "https://pubmed.ncbi.nlm.nih.gov/33606296/", "https://pubmed.ncbi.nlm.nih.gov/33854395/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/", "https://pubmed.ncbi.nlm.nih.gov/33863748/", "https://onlinelibrary.wiley.com/doi/10.1002/ana.26172", "https://pubmed.ncbi.nlm.nih.gov/34133027/", "https://pubmed.ncbi.nlm.nih.gov/34001390/", "https://pubmed.ncbi.nlm.nih.gov/34181446/", "https://pubmed.ncbi.nlm.nih.gov/34174723/", "https://www.nature.com/articles/s41591-021-01408-4", "https://pubmed.ncbi.nlm.nih.gov/34075578/", "https://pubmed.ncbi.nlm.nih.gov/34105244/", "https://www.nejm.org/doi/full/10.1056/NEJMc2106383", "https://www.nature.com/articles/s41586-021-03744-4", "https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135", "https://jamanetwork.com/journals/jama/fullarticle/2782900", "https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891", "https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf", "https://pubmed.ncbi.nlm.nih.gov/33994339/", "https://www.sciencedirect.com/science/article/pii/S1553838921005789", "https://www.sciencedirect.com/science/article/pii/S1871402121002253", "https://www.sciencedirect.com/science/article/pii/S1936878X2100485X", "https://www.sciencedirect.com/science/article/pii/S002234762100617X", "https://www.sciencedirect.com/science/article/pii/S0167527321012286", "https://www.sciencedirect.com/science/article/pii/S2214250921001530", "https://www.sciencedirect.com/science/article/pii/S2352906721001573", "https://www.sciencedirect.com/science/article/pii/S0735675721005362", "https://www.sciencedirect.com/science/article/pii/S1930043321005549", "https://www.sciencedirect.com/science/article/pii/S002234762100665X", "https://www.sciencedirect.com/science/article/pii/S1885585721002218", "https://www.sciencedirect.com/science/article/pii/S2589790X21001931", "https://www.sciencedirect.com/science/article/pii/S2352906721000622", "https://www.sciencedirect.com/science/article/pii/S0022347621007368", "https://www.sciencedirect.com/science/article/pii/S0870255121003243", "https://www.sciencedirect.com/science/article/pii/S0022347621007496", "https://www.sciencedirect.com/science/article/pii/S1936878X21004861", "https://www.sciencedirect.com/science/article/pii/S1443950621011331", "https://pubmed.ncbi.nlm.nih.gov/34268277/", "https://pubmed.ncbi.nlm.nih.gov/34399967/", "https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc%20e/en/covidwho-1360706", "https://pubmed.ncbi.nlm.nih.gov/34246566/", "https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-complications-of-the-mrna-based-covid-19-vaccines", "https://pubmed.ncbi.nlm.nih.gov/34340927/", "https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135", "https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co%20vid-19-vaccine-in-children/", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600", "https://www.nejm.org/doi/full/10.1056/NEJMc2109975", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602", "https://pubs.rsna.org/doi/10.1148/radiol.2021211430", "https://pediatrics.aappublications.org/content/148/3/e2021052478", "https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4", "https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocarditis-and-pericarditis", "https://pubmed.ncbi.nlm.nih.gov/34402228/", "https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567", "https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html", "https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce%20nts_Receiving.95800.aspx", "https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543", "https://pubmed.ncbi.nlm.nih.gov/34312010/", "https://pubmed.ncbi.nlm.nih.gov/34219532/", "https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033", "https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236", "https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038", "https://pubmed.ncbi.nlm.nih.gov/34333695/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/", "https://pubmed.ncbi.nlm.nih.gov/34118375/", "https://pubmed.ncbi.nlm.nih.gov/34180390/", "https://pubmed.ncbi.nlm.nih.gov/34133825/", "https://pubmed.ncbi.nlm.nih.gov/34487236/", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059", "https://pubmed.ncbi.nlm.nih.gov/34447639/", "https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183", "https://pubmed.ncbi.nlm.nih.gov/34236331/", "https://pubmed.ncbi.nlm.nih.gov/34435250/", "https://pubmed.ncbi.nlm.nih.gov/34186348/", "https://www.sciencedirect.com/science/article/pii/S2666354621000065", "https://www.sciencedirect.com/science/article/pii/S0303846721004169", "https://www.sciencedirect.com/science/article/pii/S0165572821002186", "https://www.sciencedirect.com/science/article/pii/S2214250921000998", "https://www.sciencedirect.com/science/article/pii/S0736467921006442", "https://www.sciencedirect.com/science/article/pii/S0035378721005853", "https://www.sciencedirect.com/science/article/pii/S2049080121005343", "https://www.sciencedirect.com/science/article/pii/S2049080121007536", "https://www.sciencedirect.com/science/article/pii/S1201971221007049", "https://www.sciencedirect.com/science/article/pii/S0899707121003557", "https://www.sciencedirect.com/science/article/pii/S0165572821001569", "https://www.sciencedirect.com/science/article/pii/S0165572821002137", "https://www.sciencedirect.com/science/article/pii/S1473309921002735", "https://www.sciencedirect.com/science/article/pii/S266635462100020X", "https://www.sciencedirect.com/science/article/pii/S2451993621001456", "https://www.sciencedirect.com/science/article/pii/S217358082100122X", "https://www.sciencedirect.com/science/article/pii/S2213219821007972", "https://www.sciencedirect.com/science/article/pii/S1930043321002612", "https://www.sciencedirect.com/science/article/pii/S0272638621007423", "https://www.sciencedirect.com/science/article/pii/S2213219821007996", "https://www.sciencedirect.com/science/article/pii/S1871402121001880", "https://www.sciencedirect.com/science/article/pii/S0190962221024427", "https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381", "https://www.sciencedirect.com/science/article/pii/S1939455121000119", "https://www.sciencedirect.com/science/article/pii/S1871402121002046", "https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X", "https://www.sciencedirect.com/science/article/pii/S0896841121000937", "https://www.sciencedirect.com/science/article/pii/S2214250921002018", "https://www.sciencedirect.com/science/article/pii/S1876034121001878", "https://www.nejm.org/doi/full/10.1056/NEJMoa2104983", "https://www.researchsquare.com/article/rs-477964/v1", "https://link.springer.com/article/10.1007/s00415-021-10780-7", "https://pubmed.ncbi.nlm.nih.gov/33475702/", "https://pubmed.ncbi.nlm.nih.gov/33320974/", "https://pubmed.ncbi.nlm.nih.gov/33384356/", "https://pubmed.ncbi.nlm.nih.gov/33444297/", "https://pubmed.ncbi.nlm.nih.gov/33507892/", "https://pubmed.ncbi.nlm.nih.gov/34414880/", "https://pubmed.ncbi.nlm.nih.gov/33576785/", "https://pubmed.ncbi.nlm.nih.gov/34269740/", "https://pubmed.ncbi.nlm.nih.gov/34215453/", "https://pubmed.ncbi.nlm.nih.gov/33932618/", "https://pubmed.ncbi.nlm.nih.gov/33643776/", "https://pubmed.ncbi.nlm.nih.gov/33571463/", "https://pubmed.ncbi.nlm.nih.gov/33527524/", "https://pubmed.ncbi.nlm.nih.gov/34518015/", "https://pubmed.ncbi.nlm.nih.gov/34347278/", "https://pubmed.ncbi.nlm.nih.gov/33685103/", "https://pubmed.ncbi.nlm.nih.gov/34050949/", "https://pubmed.ncbi.nlm.nih.gov/33657648/", "https://pubmed.ncbi.nlm.nih.gov/33825239/", "https://pubmed.ncbi.nlm.nih.gov/33683290/", "https://pubmed.ncbi.nlm.nih.gov/33919151/", "https://pubmed.ncbi.nlm.nih.gov/34128049/", "https://pubmed.ncbi.nlm.nih.gov/34474708/", "https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447", "https://pubmed.ncbi.nlm.nih.gov/34318537/", "https://pubmed.ncbi.nlm.nih.gov/34463751/", "https://pubmed.ncbi.nlm.nih.gov/33752263/", "https://pubmed.ncbi.nlm.nih.gov/34073536/", "https://pubmed.ncbi.nlm.nih.gov/33928772/", "https://pubmed.ncbi.nlm.nih.gov/34423106/", "https://pubmed.ncbi.nlm.nih.gov/33838206/", "https://pubmed.ncbi.nlm.nih.gov/34517079/", "https://pubmed.ncbi.nlm.nih.gov/34254291/", "https://pubmed.ncbi.nlm.nih.gov/34487581/", "https://pubmed.ncbi.nlm.nih.gov/33987882/", "https://pubmed.ncbi.nlm.nih.gov/34138513/", "https://pubmed.ncbi.nlm.nih.gov/34402235/", "https://pubmed.ncbi.nlm.nih.gov/34446426/", "https://pubmed.ncbi.nlm.nih.gov/34365148/", "https://pubmed.ncbi.nlm.nih.gov/34452064/", "https://pubmed.ncbi.nlm.nih.gov/33917902/", "https://pubmed.ncbi.nlm.nih.gov/34256983/", "https://pubmed.ncbi.nlm.nih.gov/34247246/", "https://pubmed.ncbi.nlm.nih.gov/34132839/", "https://pubmed.ncbi.nlm.nih.gov/34117206/", "https://pubmed.ncbi.nlm.nih.gov/34033927/", "https://pubmed.ncbi.nlm.nih.gov/34277198/", "https://pubmed.ncbi.nlm.nih.gov/34364831/", "https://pubmed.ncbi.nlm.nih.gov/34447639/", "https://pubmed.ncbi.nlm.nih.gov/34514306/", "https://pubmed.ncbi.nlm.nih.gov/33946748/", "https://pubmed.ncbi.nlm.nih.gov/34453510/", "https://pubmed.ncbi.nlm.nih.gov/33476455/", "https://pubmed.ncbi.nlm.nih.gov/34451967/", "https://pubmed.ncbi.nlm.nih.gov/34377889/", "https://pubmed.ncbi.nlm.nih.gov/34272095/", "https://pubmed.ncbi.nlm.nih.gov/34165512/", "https://pubmed.ncbi.nlm.nih.gov/34411533/", "https://pubmed.ncbi.nlm.nih.gov/33611630/", "https://pubmed.ncbi.nlm.nih.gov/33981305/", "https://pubmed.ncbi.nlm.nih.gov/34336436/", "https://pubmed.ncbi.nlm.nih.gov/34281950/", "https://pubmed.ncbi.nlm.nih.gov/34458035/", "https://pubmed.ncbi.nlm.nih.gov/33734623/", "https://pubmed.ncbi.nlm.nih.gov/34044114/", "https://pubmed.ncbi.nlm.nih.gov/34492394/", "https://pubmed.ncbi.nlm.nih.gov/34369471/", "https://pubmed.ncbi.nlm.nih.gov/34014316/", "https://pubmed.ncbi.nlm.nih.gov/34330676/", "https://pubmed.ncbi.nlm.nih.gov/34272622/", "https://pubmed.ncbi.nlm.nih.gov/34477091/", "https://pubmed.ncbi.nlm.nih.gov/33975372/", "https://pubmed.ncbi.nlm.nih.gov/34322761/", "https://pubmed.ncbi.nlm.nih.gov/34139321/", "https://pubmed.ncbi.nlm.nih.gov/34032902/", "https://pubmed.ncbi.nlm.nih.gov/33862041/", "https://pubmed.ncbi.nlm.nih.gov/34332438/", "https://pubmed.ncbi.nlm.nih.gov/34293683/", "https://pubmed.ncbi.nlm.nih.gov/34225251/", "https://pubmed.ncbi.nlm.nih.gov/34449715/", "https://pubmed.ncbi.nlm.nih.gov/34139631/", "https://pubmed.ncbi.nlm.nih.gov/33864750/", "https://pubmed.ncbi.nlm.nih.gov/33914590/", "https://pubmed.ncbi.nlm.nih.gov/34420802/", "https://pubmed.ncbi.nlm.nih.gov/34293217/", "https://pubmed.ncbi.nlm.nih.gov/34446426/", "https://pubmed.ncbi.nlm.nih.gov/34174723/", "https://pubmed.ncbi.nlm.nih.gov/33952445/", "https://pubmed.ncbi.nlm.nih.gov/34108714/", "https://pubmed.ncbi.nlm.nih.gov/34288044/", "https://pubmed.ncbi.nlm.nih.gov/34341358/", "https://pubmed.ncbi.nlm.nih.gov/34261633/", "https://pubmed.ncbi.nlm.nih.gov/34256983/", "https://pubmed.ncbi.nlm.nih.gov/34332437/", "https://pubmed.ncbi.nlm.nih.gov/33845870/", "https://pubmed.ncbi.nlm.nih.gov/34236343/", "https://pubmed.ncbi.nlm.nih.gov/34364657/", "https://pubmed.ncbi.nlm.nih.gov/34287612/", "https://pubmed.ncbi.nlm.nih.gov/34478433/", "https://pubmed.ncbi.nlm.nih.gov/34402235/", "https://pubmed.ncbi.nlm.nih.gov/34186376/", "https://pubmed.ncbi.nlm.nih.gov/34101024/", "https://pubmed.ncbi.nlm.nih.gov/34137813/", "https://pubmed.ncbi.nlm.nih.gov/34191218/", "https://pubmed.ncbi.nlm.nih.gov/34175640/", "https://pubmed.ncbi.nlm.nih.gov/34153802/", "https://pubmed.ncbi.nlm.nih.gov/34092488/", "https://pubmed.ncbi.nlm.nih.gov/34261635/", "https://pubmed.ncbi.nlm.nih.gov/34132839/", "https://pubmed.ncbi.nlm.nih.gov/34144250/", "https://pubmed.ncbi.nlm.nih.gov/33687691/", "https://pubmed.ncbi.nlm.nih.gov/34011137/", "https://pubmed.ncbi.nlm.nih.gov/34393988/", "https://pubmed.ncbi.nlm.nih.gov/34129181/", "https://pubmed.ncbi.nlm.nih.gov/34083026/", "https://pubmed.ncbi.nlm.nih.gov/34247246/", "https://pubmed.ncbi.nlm.nih.gov/34235757/", "https://pubmed.ncbi.nlm.nih.gov/34473841/", "https://pubmed.ncbi.nlm.nih.gov/34189756/", "https://pubmed.ncbi.nlm.nih.gov/34045111/", "https://pubmed.ncbi.nlm.nih.gov/34366434/", "https://pubmed.ncbi.nlm.nih.gov/34330677/", "https://pubmed.ncbi.nlm.nih.gov/34181446/", "https://pubmed.ncbi.nlm.nih.gov/34477089/", "https://pubmed.ncbi.nlm.nih.gov/34071883/", "https://pubmed.ncbi.nlm.nih.gov/34033367/", "https://pubmed.ncbi.nlm.nih.gov/34375510/", "https://pubmed.ncbi.nlm.nih.gov/34107198/", "https://pubmed.ncbi.nlm.nih.gov/34355379/", "https://pubmed.ncbi.nlm.nih.gov/34452028/", "https://pubmed.ncbi.nlm.nih.gov/34202817/", "https://pubmed.ncbi.nlm.nih.gov/34237213/", "https://pubmed.ncbi.nlm.nih.gov/34105247/", "https://pubmed.ncbi.nlm.nih.gov/34405870/", "https://pubmed.ncbi.nlm.nih.gov/34416410/", "https://pubmed.ncbi.nlm.nih.gov/34462013/", "https://pubmed.ncbi.nlm.nih.gov/34224024/", "https://pubmed.ncbi.nlm.nih.gov/34324214/", "https://pubmed.ncbi.nlm.nih.gov/34507266/", "https://pubmed.ncbi.nlm.nih.gov/34459725/", "https://pubmed.ncbi.nlm.nih.gov/34463066/", "https://pubmed.ncbi.nlm.nih.gov/34043800/", "https://pubmed.ncbi.nlm.nih.gov/34447646/", "https://pubmed.ncbi.nlm.nih.gov/34479760/", "https://pubmed.ncbi.nlm.nih.gov/34416319/", "https://pubmed.ncbi.nlm.nih.gov/34092166/", "https://pubmed.ncbi.nlm.nih.gov/34291477/", "https://pubmed.ncbi.nlm.nih.gov/34513435/", "https://pubmed.ncbi.nlm.nih.gov/34512037/", "https://pubmed.ncbi.nlm.nih.gov/34483273/", "https://pubmed.ncbi.nlm.nih.gov/34513446/", "https://pubmed.ncbi.nlm.nih.gov/34474550/", "https://pubmed.ncbi.nlm.nih.gov/34033732/", "https://pubmed.ncbi.nlm.nih.gov/33858208/", "https://pubmed.ncbi.nlm.nih.gov/34015240/", "https://pubmed.ncbi.nlm.nih.gov/34482558/", "https://pubmed.ncbi.nlm.nih.gov/34480607/", "https://pubmed.ncbi.nlm.nih.gov/34462647/", "https://pubmed.ncbi.nlm.nih.gov/34325334/", "https://pubmed.ncbi.nlm.nih.gov/34513398/", "https://pubmed.ncbi.nlm.nih.gov/34362727/", "https://pubmed.ncbi.nlm.nih.gov/34469919/", "https://pubmed.ncbi.nlm.nih.gov/34516272/", "https://pubmed.ncbi.nlm.nih.gov/34512961/", "https://pubmed.ncbi.nlm.nih.gov/34077949/", "https://pubmed.ncbi.nlm.nih.gov/34171435/", "https://pubmed.ncbi.nlm.nih.gov/34447349/", "https://pubmed.ncbi.nlm.nih.gov/34514078/", "https://pubmed.ncbi.nlm.nih.gov/34406660/", "https://pubmed.ncbi.nlm.nih.gov/34509658/", "https://pubmed.ncbi.nlm.nih.gov/34196469/", "https://pubmed.ncbi.nlm.nih.gov/34350668/", "https://pubmed.ncbi.nlm.nih.gov/34436620/", "https://pubmed.ncbi.nlm.nih.gov/34116295/", "https://pubmed.ncbi.nlm.nih.gov/34509271/", "https://pubmed.ncbi.nlm.nih.gov/34462996/", "https://pubmed.ncbi.nlm.nih.gov/34435486/", "https://pubmed.ncbi.nlm.nih.gov/34435142/", "https://pubmed.ncbi.nlm.nih.gov/34429981/", "https://pubmed.ncbi.nlm.nih.gov/34427024/", "https://pubmed.ncbi.nlm.nih.gov/34510014/", "https://pubmed.ncbi.nlm.nih.gov/34236711/", "https://pubmed.ncbi.nlm.nih.gov/34525282/", "https://pubmed.ncbi.nlm.nih.gov/34515024/", "https://pubmed.ncbi.nlm.nih.gov/34435250/", "https://pubmed.ncbi.nlm.nih.gov/34363637/", "https://www.sciencedirect.com/science/article/pii/S2214250921002018", "https://casereports.bmj.com/content/14/5/e242220.abstract", "https://pubmed.ncbi.nlm.nih.gov/34155844/", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/", "https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext", "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/", "https://casereports.bmj.com/content/14/7/e242678", "https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic", "https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794", "https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-induce-severe-hemolysis-in", "https://pubmed.ncbi.nlm.nih.gov/34288044/", "https://pubmed.ncbi.nlm.nih.gov/34327553/", "https://pubmed.ncbi.nlm.nih.gov/33878469/", "https://pubmed.ncbi.nlm.nih.gov/33857630/", "https://pubmed.ncbi.nlm.nih.gov/34090750/", "https://pubmed.ncbi.nlm.nih.gov/34312301/", "https://pubmed.ncbi.nlm.nih.gov/34333995/", "https://pubmed.ncbi.nlm.nih.gov/34455073/", "https://pubmed.ncbi.nlm.nih.gov/34111775/", "https://pubmed.ncbi.nlm.nih.gov/34045111/", "https://pubmed.ncbi.nlm.nih.gov/33983464/", "https://pubmed.ncbi.nlm.nih.gov/34116145/", "https://pubmed.ncbi.nlm.nih.gov/34286453/", "https://pubmed.ncbi.nlm.nih.gov/34478433/", "https://pubmed.ncbi.nlm.nih.gov/34244448/", "https://pubmed.ncbi.nlm.nih.gov/34226070/", "https://pubmed.ncbi.nlm.nih.gov/33845870/", "https://pubmed.ncbi.nlm.nih.gov/34101024/", "https://pubmed.ncbi.nlm.nih.gov/34393988/", "https://pubmed.ncbi.nlm.nih.gov/34407607/", "https://pubmed.ncbi.nlm.nih.gov/34313952/", "https://pubmed.ncbi.nlm.nih.gov/34092166/", "https://pubmed.ncbi.nlm.nih.gov/34293217/", "https://pubmed.ncbi.nlm.nih.gov/34274191/", "https://pubmed.ncbi.nlm.nih.gov/34186376/", "https://pubmed.ncbi.nlm.nih.gov/33952445/", "https://pubmed.ncbi.nlm.nih.gov/34129181/", "https://pubmed.ncbi.nlm.nih.gov/33929487/", "https://pubmed.ncbi.nlm.nih.gov/34341358/", "https://pubmed.ncbi.nlm.nih.gov/34175640/", "https://pubmed.ncbi.nlm.nih.gov/34159588/", "https://pubmed.ncbi.nlm.nih.gov/34402666/", "https://pubmed.ncbi.nlm.nih.gov/34508917/", "https://pubmed.ncbi.nlm.nih.gov/34370974/", "https://pubmed.ncbi.nlm.nih.gov/34373991/", "https://pubmed.ncbi.nlm.nih.gov/34490632/", "https://pubmed.ncbi.nlm.nih.gov/33909350/", "https://pubmed.ncbi.nlm.nih.gov/33981305/", "https://pubmed.ncbi.nlm.nih.gov/34272622/", "https://pubmed.ncbi.nlm.nih.gov/33877737/", "https://pubmed.ncbi.nlm.nih.gov/34254476/", "https://pubmed.ncbi.nlm.nih.gov/34108714/", "https://pubmed.ncbi.nlm.nih.gov/34483267/", "https://pubmed.ncbi.nlm.nih.gov/34261635/", "https://pubmed.ncbi.nlm.nih.gov/34202817/", "https://pubmed.ncbi.nlm.nih.gov/34273119/", "https://pubmed.ncbi.nlm.nih.gov/34463066/", "https://pubmed.ncbi.nlm.nih.gov/34276917/", "https://pubmed.ncbi.nlm.nih.gov/34237213/", "https://pubmed.ncbi.nlm.nih.gov/34268278/", "https://pubmed.ncbi.nlm.nih.gov/33990339/", "https://pubmed.ncbi.nlm.nih.gov/34479760/", "https://pubmed.ncbi.nlm.nih.gov/34314875/", "https://pubmed.ncbi.nlm.nih.gov/34384129/", "https://pubmed.ncbi.nlm.nih.gov/34382387/", "https://pubmed.ncbi.nlm.nih.gov/34416184/", "https://pubmed.ncbi.nlm.nih.gov/34261297/", "https://pubmed.ncbi.nlm.nih.gov/34261296/", "https://pubmed.ncbi.nlm.nih.gov/34250318/", "https://pubmed.ncbi.nlm.nih.gov/34059191/", "https://pubmed.ncbi.nlm.nih.gov/34189756/", "https://pubmed.ncbi.nlm.nih.gov/34331506/", "https://pubmed.ncbi.nlm.nih.gov/34525282/", "https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1", "https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09", "https://onlinelibrary.wiley.com/doi/10.1111/trf.16672", "https://t.co/j0IEM8cMXI", "https://pubmed.ncbi.nlm.nih.gov/34601006/", "https://www.nejm.org/doi/full/10.1056/NEJMoa2110475", "https://www.sciencedirect.com/science/article/pii/S1201971221007797", "https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1", "https://www.sciencedirect.com/science/article/pii/S0168827821020936", "https://www.nature.com/articles/s41421-021-00329-3", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/", "https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712", "https://pubmed.ncbi.nlm.nih.gov/34626338/", "https://europepmc.org/article/PPR/PPR304469%20435", "https://pubmed.ncbi.nlm.nih.gov/34731555/", "https://pubmed.ncbi.nlm.nih.gov/34159588/", "https://pubmed.ncbi.nlm.nih.gov/34461442/", "https://pubmed.ncbi.nlm.nih.gov/34719776/", "https://pubmed.ncbi.nlm.nih.gov/34370974/", "https://pubmed.ncbi.nlm.nih.gov/34373413/", "https://pubmed.ncbi.nlm.nih.gov/34598301/", "https://pubmed.ncbi.nlm.nih.gov/34620638/", "https://pubmed.ncbi.nlm.nih.gov/34650896/", "https://pubmed.ncbi.nlm.nih.gov/34625447/", "https://pubmed.ncbi.nlm.nih.gov/34696248/", "https://pubmed.ncbi.nlm.nih.gov/34548920/", "https://pubmed.ncbi.nlm.nih.gov/34672380/", "https://pubmed.ncbi.nlm.nih.gov/34556531/", "https://pubmed.ncbi.nlm.nih.gov/34535076/", "https://pubmed.ncbi.nlm.nih.gov/34379914/", "https://pubmed.ncbi.nlm.nih.gov/34545400/", "https://pubmed.ncbi.nlm.nih.gov/34035134/", "https://pubmed.ncbi.nlm.nih.gov/34688190/", "https://pubmed.ncbi.nlm.nih.gov/34782400/", "https://pubmed.ncbi.nlm.nih.gov/34710832/", "https://pubmed.ncbi.nlm.nih.gov/34695859/", "https://pubmed.ncbi.nlm.nih.gov/34453762/", "https://pubmed.ncbi.nlm.nih.gov/34660652/", "https://pubmed.ncbi.nlm.nih.gov/34644642/", "https://pubmed.ncbi.nlm.nih.gov/34694650/", "https://pubmed.ncbi.nlm.nih.gov/34726934/", "https://pubmed.ncbi.nlm.nih.gov/34835237/", "https://pubmed.ncbi.nlm.nih.gov/34261297/", "https://pubmed.ncbi.nlm.nih.gov/34724036/", "https://pubmed.ncbi.nlm.nih.gov/34839563/", "https://pubmed.ncbi.nlm.nih.gov/34783932/", "https://pubmed.ncbi.nlm.nih.gov/34624910/", "https://pubmed.ncbi.nlm.nih.gov/34585145/", "https://pubmed.ncbi.nlm.nih.gov/34580132/", "https://pubmed.ncbi.nlm.nih.gov/34535492/", "https://pubmed.ncbi.nlm.nih.gov/34527501/", "https://pubmed.ncbi.nlm.nih.gov/34272095/", "https://pubmed.ncbi.nlm.nih.gov/34756770/", "https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622", "https://pubmed.ncbi.nlm.nih.gov/34781321/", "https://pubmed.ncbi.nlm.nih.gov/34062319/", "https://pubmed.ncbi.nlm.nih.gov/34706921/", "https://pubmed.ncbi.nlm.nih.gov/34698582/", "https://pubmed.ncbi.nlm.nih.gov/34751013/", "https://pubmed.ncbi.nlm.nih.gov/34684047/", "https://pubmed.ncbi.nlm.nih.gov/34541935/", "https://pubmed.ncbi.nlm.nih.gov/34273119/", "https://pubmed.ncbi.nlm.nih.gov/34327553/", "https://pubmed.ncbi.nlm.nih.gov/33877737/", "https://pubmed.ncbi.nlm.nih.gov/34646685/", "https://pubmed.ncbi.nlm.nih.gov/34242687/", "https://pubmed.ncbi.nlm.nih.gov/34609603/", "https://pubmed.ncbi.nlm.nih.gov/34557507/", "https://pubmed.ncbi.nlm.nih.gov/34641797/", "https://pubmed.ncbi.nlm.nih.gov/34812326/", "https://pubmed.ncbi.nlm.nih.gov/34006408/", "https://pubmed.ncbi.nlm.nih.gov/34416184/", "https://pubmed.ncbi.nlm.nih.gov/34664303/", "https://pubmed.ncbi.nlm.nih.gov/34649281/", "https://pubmed.ncbi.nlm.nih.gov/34420249/", "https://pubmed.ncbi.nlm.nih.gov/34610990/", "https://pubmed.ncbi.nlm.nih.gov/34590397/", "https://pubmed.ncbi.nlm.nih.gov/34670143/", "https://pubmed.ncbi.nlm.nih.gov/34819146/", "https://pubmed.ncbi.nlm.nih.gov/34581453/", "https://pubmed.ncbi.nlm.nih.gov/34741583/", "https://pubmed.ncbi.nlm.nih.gov/34631069/", "https://pubmed.ncbi.nlm.nih.gov/34479129/", "https://pubmed.ncbi.nlm.nih.gov/34331506/", "https://pubmed.ncbi.nlm.nih.gov/34546608/", "https://pubmed.ncbi.nlm.nih.gov/34546343/", "https://pubmed.ncbi.nlm.nih.gov/34849183/", "https://pubmed.ncbi.nlm.nih.gov/34853744/", "https://pubmed.ncbi.nlm.nih.gov/34751429/", "https://pubmed.ncbi.nlm.nih.gov/34559576/", "https://pubmed.ncbi.nlm.nih.gov/34608345/", "https://pubmed.ncbi.nlm.nih.gov/34384129/", "https://pubmed.ncbi.nlm.nih.gov/34755433/", "https://pubmed.ncbi.nlm.nih.gov/34839830/", "https://pubmed.ncbi.nlm.nih.gov/34667486/", "https://pubmed.ncbi.nlm.nih.gov/34726187/", "https://pubmed.ncbi.nlm.nih.gov/34781027/", "https://pubmed.ncbi.nlm.nih.gov/34595694/", "https://pubmed.ncbi.nlm.nih.gov/34661934/", "https://pubmed.ncbi.nlm.nih.gov/34788138", "https://pubmed.ncbi.nlm.nih.gov/34753210/", "https://pubmed.ncbi.nlm.nih.gov/34653943/", "https://pubmed.ncbi.nlm.nih.gov/34591991/", "https://pubmed.ncbi.nlm.nih.gov/34650382/", "https://pubmed.ncbi.nlm.nih.gov/34769454/", "https://pubmed.ncbi.nlm.nih.gov/34786893/", "https://pubmed.ncbi.nlm.nih.gov/34833382/", "https://pubmed.ncbi.nlm.nih.gov/34670287/", "https://pubmed.ncbi.nlm.nih.gov/34790811/", "https://pubmed.ncbi.nlm.nih.gov/34023956/", "https://pubmed.ncbi.nlm.nih.gov/34629931/", "https://pubmed.ncbi.nlm.nih.gov/34402666/", "https://pubmed.ncbi.nlm.nih.gov/34842783/", "https://pubmed.ncbi.nlm.nih.gov/34630307/", "https://pubmed.ncbi.nlm.nih.gov/33983464/", "https://pubmed.ncbi.nlm.nih.gov/34508917/", "https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext", "https://pubmed.ncbi.nlm.nih.gov/33962903/", "https://pubmed.ncbi.nlm.nih.gov/34796065/", "https://pubmed.ncbi.nlm.nih.gov/34579248/", "https://pubmed.ncbi.nlm.nih.gov/34843991/", "https://pubmed.ncbi.nlm.nih.gov/34595867/", "https://pubmed.ncbi.nlm.nih.gov/34820240/", "https://pubmed.ncbi.nlm.nih.gov/33851389/", "https://pubmed.ncbi.nlm.nih.gov/33980419/", "https://pubmed.ncbi.nlm.nih.gov/34264151/", "https://pubmed.ncbi.nlm.nih.gov/34734086/", "https://pubmed.ncbi.nlm.nih.gov/34755555/", "https://pubmed.ncbi.nlm.nih.gov/34407607/", "https://pubmed.ncbi.nlm.nih.gov/34264514/", "https://pubmed.ncbi.nlm.nih.gov/34840204/", "https://pubmed.ncbi.nlm.nih.gov/34750810/", "https://pubmed.ncbi.nlm.nih.gov/34639132/", "https://pubmed.ncbi.nlm.nih.gov/34804412/", "https://pubmed.ncbi.nlm.nih.gov/34571653/", "https://pubmed.ncbi.nlm.nih.gov/34835275/", "https://pubmed.ncbi.nlm.nih.gov/34659839/", "https://pubmed.ncbi.nlm.nih.gov/34668274/", "https://pubmed.ncbi.nlm.nih.gov/34549821/", "https://pubmed.ncbi.nlm.nih.gov/34528522/", "https://pubmed.ncbi.nlm.nih.gov/34568726/", "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644%205179", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408", "https://www.mdpi.com/2075-4426/11/11/1106", "https://pubmed.ncbi.nlm.nih.gov/34402230/", "https://pubmed.ncbi.nlm.nih.gov/34696294/", "https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_%20mRNA_COVID_19_Vaccine.9.aspx", "https://pubmed.ncbi.nlm.nih.gov/34614328/", "https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext", "https://pubmed.ncbi.nlm.nih.gov/34277198/", "https://pubmed.ncbi.nlm.nih.gov/34246586/", "https://pubmed.ncbi.nlm.nih.gov/34856634/", "https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/", "https://www.nejm.org/doi/10.1056/NEJMoa2110737", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052", "https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed", "https://pubmed.ncbi.nlm.nih.gov/34756746/", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/", "https://pubmed.ncbi.nlm.nih.gov/34546329/", "https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602", "https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub", "https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357", "https://pubmed.ncbi.nlm.nih.gov/34704459/", "https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6%20421640", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/", "https://www.sciencedirect.com/science/article/pii/S2352906721001603", "https://pubmed.ncbi.nlm.nih.gov/34712717/", "https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administration-bnt162b2-S188558572100133X", "https://pubs.rsna.org/doi/10.1148/radiol.2021211430", "https://www.sciencedirect.com/science/article/pii/S0248866321007098", "https://pubmed.ncbi.nlm.nih.gov/34589238/", "https://academic.oup.com/jpids/article/10/10/962/6329543", "https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196", "https://pubmed.ncbi.nlm.nih.gov/34428917/", "https://pubmed.ncbi.nlm.nih.gov/34088762/", "https://www.mdpi.com/2036-7503/13/3/61", "https://pubmed.ncbi.nlm.nih.gov/34402228/", "https://pubmed.ncbi.nlm.nih.gov/34133885/", "https://pubmed.ncbi.nlm.nih.gov/34219532/", "https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/", "https://pubmed.ncbi.nlm.nih.gov/34840235/", "https://pubmed.ncbi.nlm.nih.gov/34712497/", "https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext", "https://pubmed.ncbi.nlm.nih.gov/34568726/", "https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179", "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408", "https://www.mdpi.com/2075-4426/11/11/1106", "https://pubmed.ncbi.nlm.nih.gov/34402230/", "https://pubmed.ncbi.nlm.nih.gov/34696294/", "https://pubmed.ncbi.nlm.nih.gov/34615534/", "https://pubmed.ncbi.nlm.nih.gov/34352418/", "https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340", "https://pubmed.ncbi.nlm.nih.gov/34632750/", "https://haematologica.org/article/view/haematol.2021.279075", "https://pubmed.ncbi.nlm.nih.gov/34802488/", "https://pubmed.ncbi.nlm.nih.gov/34887867/", "https://pubmed.ncbi.nlm.nih.gov/34863404/", "https://www.sciencedirect.com/science/article/pii/S235255682100093X", "https://pubmed.ncbi.nlm.nih.gov/34876440/", "https://pubmed.ncbi.nlm.nih.gov/33928773/", "https://pubmed.ncbi.nlm.nih.gov/34880826/", "https://pubmed.ncbi.nlm.nih.gov/34587242/", "https://pubmed.ncbi.nlm.nih.gov/34868465/", "https://pubmed.ncbi.nlm.nih.gov/34097311/", "https://pubmed.ncbi.nlm.nih.gov/34820232/", "https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258", "https://pubmed.ncbi.nlm.nih.gov/34579636/", "https://pubmed.ncbi.nlm.nih.gov/34614491/", "https://pubmed.ncbi.nlm.nih.gov/34790684/", "https://pubmed.ncbi.nlm.nih.gov/33624509/", "https://pubmed.ncbi.nlm.nih.gov/34612003/", "https://pubmed.ncbi.nlm.nih.gov/34096082/", "https://pubmed.ncbi.nlm.nih.gov/34851078/", "https://pubmed.ncbi.nlm.nih.gov/34496880/", "https://pubmed.ncbi.nlm.nih.gov/34866957/", "https://pubmed.ncbi.nlm.nih.gov/34849657/", "https://pubmed.ncbi.nlm.nih.gov/34664804/", "https://pubmed.ncbi.nlm.nih.gov/34605853/", "https://pubmed.ncbi.nlm.nih.gov/34166671/", "https://pubmed.ncbi.nlm.nih.gov/34744118/", "https://pubmed.ncbi.nlm.nih.gov/34334935/", "https://pubmed.ncbi.nlm.nih.gov/34746968/", "https://pubmed.ncbi.nlm.nih.gov/34333695/", "https://pubmed.ncbi.nlm.nih.gov/34180390/", "https://pubmed.ncbi.nlm.nih.gov/34185045/", "https://pubmed.ncbi.nlm.nih.gov/34229940/", "https://pubmed.ncbi.nlm.nih.gov/34133825/", "https://pubmed.ncbi.nlm.nih.gov/34308326/", "https://pubmed.ncbi.nlm.nih.gov/34866106/", "https://pubmed.ncbi.nlm.nih.gov/34487236/", "https://pubmed.ncbi.nlm.nih.gov/34848416/", "https://pubmed.ncbi.nlm.nih.gov/34636504/", "https://pubmed.ncbi.nlm.nih.gov/34367386/", "https://pubmed.ncbi.nlm.nih.gov/34709227/", "https://pubmed.ncbi.nlm.nih.gov/34778411/", "https://pubmed.ncbi.nlm.nih.gov/34734821/", "https://pubmed.ncbi.nlm.nih.gov/34246585/", "https://pubmed.ncbi.nlm.nih.gov/34228985/", "https://pubmed.ncbi.nlm.nih.gov/34852213/", "https://pubmed.ncbi.nlm.nih.gov/34866122/", "https://pubmed.ncbi.nlm.nih.gov/34601566/", "https://pubmed.ncbi.nlm.nih.gov/34739045/", "https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e", "https://pubmed.ncbi.nlm.nih.gov/34374740/", "https://pubmed.ncbi.nlm.nih.gov/34865500/", "https://pubmed.ncbi.nlm.nih.gov/34614329/", "https://pubmed.ncbi.nlm.nih.gov/34560365/", "https://pubmed.ncbi.nlm.nih.gov/34108736/", "https://pubmed.ncbi.nlm.nih.gov/34796417/", "https://link.springer.com/article/10.1007%2Fs10072-021-05523-5", "https://onlinelibrary.wiley.com/doi/10.1002/ana.26258", "https://jamanetwork.com/journals/jama/fullarticle/2785009", "https://pubmed.ncbi.nlm.nih.gov/34567447/", "https://pubmed.ncbi.nlm.nih.gov/34648420/", "https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708", "https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext", "https://pubmed.ncbi.nlm.nih.gov/34114256/", "https://pubmed.ncbi.nlm.nih.gov/34767184/", "https://pubmed.ncbi.nlm.nih.gov/34644738/", "https://pubmed.ncbi.nlm.nih.gov/34649856/", "https://pubmed.ncbi.nlm.nih.gov/34671572/", "https://pubmed.ncbi.nlm.nih.gov/33758714/", "https://pubmed.ncbi.nlm.nih.gov/34484780/", "https://pubmed.ncbi.nlm.nih.gov/34779385/", "https://pubmed.ncbi.nlm.nih.gov/34817727/", "https://pubmed.ncbi.nlm.nih.gov/34789193/", "https://pubmed.ncbi.nlm.nih.gov/34261746/", "https://pubmed.ncbi.nlm.nih.gov/34217513/", "https://pubmed.ncbi.nlm.nih.gov/34871447/", "https://pubmed.ncbi.nlm.nih.gov/34579259/", "https://pubmed.ncbi.nlm.nih.gov/34370408/", "https://pubmed.ncbi.nlm.nih.gov/34703690/", "https://pubmed.ncbi.nlm.nih.gov/34810163/", "https://onlinelibrary.wiley.com/doi/10.1002/ana.26218", "https://pubmed.ncbi.nlm.nih.gov/34482455/", "https://pubmed.ncbi.nlm.nih.gov/34114269/", "https://pubmed.ncbi.nlm.nih.gov/34722067/", "https://pubmed.ncbi.nlm.nih.gov/33968610/", "https://pubmed.ncbi.nlm.nih.gov/34525410/", "https://pubmed.ncbi.nlm.nih.gov/34808658/", "https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fulltext", "https://pubmed.ncbi.nlm.nih.gov/34522557/", "https://pubmed.ncbi.nlm.nih.gov/34763263/", "https://pubmed.ncbi.nlm.nih.gov/34621891/", "https://pubmed.ncbi.nlm.nih.gov/34697502/", "https://pubmed.ncbi.nlm.nih.gov/33858693/", "https://pubmed.ncbi.nlm.nih.gov/34370410/", "https://pubmed.ncbi.nlm.nih.gov/34579245/", "https://pubmed.ncbi.nlm.nih.gov/34182207/", "https://pubmed.ncbi.nlm.nih.gov/34457267/", "https://pubmed.ncbi.nlm.nih.gov/34189662/", "https://pubmed.ncbi.nlm.nih.gov/34660149/", "https://pubmed.ncbi.nlm.nih.gov/34131771/", "https://pubmed.ncbi.nlm.nih.gov/34635376/", "https://pubmed.ncbi.nlm.nih.gov/34749492/", "https://pubmed.ncbi.nlm.nih.gov/34849667/", "https://pubmed.ncbi.nlm.nih.gov/34319393/", "https://pubmed.ncbi.nlm.nih.gov/34589238/", "https://pubmed.ncbi.nlm.nih.gov/34149145/", "https://pubmed.ncbi.nlm.nih.gov/34693198/", "https://pubmed.ncbi.nlm.nih.gov/34797392/", "https://pubmed.ncbi.nlm.nih.gov/34862234/", "https://pubmed.ncbi.nlm.nih.gov/34396358/", "https://pubmed.ncbi.nlm.nih.gov/34848426/", "https://pubmed.ncbi.nlm.nih.gov/33946748/", "https://pubmed.ncbi.nlm.nih.gov/34591186/", "https://pubmed.ncbi.nlm.nih.gov/34352309/", "https://pubmed.ncbi.nlm.nih.gov/34804803/", "https://pubmed.ncbi.nlm.nih.gov/34077572/", "https://pubmed.ncbi.nlm.nih.gov/34884407/", "https://pubmed.ncbi.nlm.nih.gov/34859017/", "https://pubmed.ncbi.nlm.nih.gov/34783899/", "https://pubmed.ncbi.nlm.nih.gov/34549178/", "https://pubmed.ncbi.nlm.nih.gov/34656887/", "https://pubmed.ncbi.nlm.nih.gov/34236717/", "https://pubmed.ncbi.nlm.nih.gov/34729467/", "https://pubmed.ncbi.nlm.nih.gov/33932458/", "https://pubmed.ncbi.nlm.nih.gov/34092400/742", "https://pubmed.ncbi.nlm.nih.gov/34754937/", "https://pubmed.ncbi.nlm.nih.gov/33771584/", "https://pubmed.ncbi.nlm.nih.gov/34846583/", "https://pubmed.ncbi.nlm.nih.gov/34073536/", "https://pubmed.ncbi.nlm.nih.gov/34411532/", "https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1", "https://pubmed.ncbi.nlm.nih.gov/33851711/", "https://pubmed.ncbi.nlm.nih.gov/34675550/", "https://pubmed.ncbi.nlm.nih.gov/34734159/", "https://pubmed.ncbi.nlm.nih.gov/34698847/", "https://pubmed.ncbi.nlm.nih.gov/34020815/", "https://pubmed.ncbi.nlm.nih.gov/33641264/", "https://pubmed.ncbi.nlm.nih.gov/33641268/", "https://pubmed.ncbi.nlm.nih.gov/33834172/", "https://pubmed.ncbi.nlm.nih.gov/34579211/", "https://pubmed.ncbi.nlm.nih.gov/34343674/", "https://pubmed.ncbi.nlm.nih.gov/34586408/", "https://pubmed.ncbi.nlm.nih.gov/34539938/", "https://pubmed.ncbi.nlm.nih.gov/34731486/", "https://pubmed.ncbi.nlm.nih.gov/33824804/", "https://pubmed.ncbi.nlm.nih.gov/34807248/", "https://pubmed.ncbi.nlm.nih.gov/34148772/", "https://pubmed.ncbi.nlm.nih.gov/34702550/", "https://pubmed.ncbi.nlm.nih.gov/33895650/", "https://pubmed.ncbi.nlm.nih.gov/34425384/", "https://pubmed.ncbi.nlm.nih.gov/34703815/", "https://pubmed.ncbi.nlm.nih.gov/34369046/", "https://pubmed.ncbi.nlm.nih.gov/34280507/", "https://pubmed.ncbi.nlm.nih.gov/34241833/", "https://pubmed.ncbi.nlm.nih.gov/34529877/", "https://pubmed.ncbi.nlm.nih.gov/33928638/", "https://pubmed.ncbi.nlm.nih.gov/34836739/", "https://pubmed.ncbi.nlm.nih.gov/34495381/", "https://pubmed.ncbi.nlm.nih.gov/34327795", "https://pubmed.ncbi.nlm.nih.gov/34660867/", "https://pubmed.ncbi.nlm.nih.gov/34659268/", "https://pubmed.ncbi.nlm.nih.gov/34848431/", "https://pubmed.ncbi.nlm.nih.gov/34310759/", "https://pubmed.ncbi.nlm.nih.gov/34720009/", "https://pubmed.ncbi.nlm.nih.gov/34518812/", "https://pubmed.ncbi.nlm.nih.gov/34611627/", "https://pubmed.ncbi.nlm.nih.gov/34705320/", "https://pubmed.ncbi.nlm.nih.gov/34779011/", "https://pubmed.ncbi.nlm.nih.gov/34451967/", "https://pubmed.ncbi.nlm.nih.gov/33928459/", "https://pubmed.ncbi.nlm.nih.gov/34250509/", "https://pubmed.ncbi.nlm.nih.gov/34292611/", "https://pubmed.ncbi.nlm.nih.gov/34530771/", "https://pubmed.ncbi.nlm.nih.gov/34245294/", "https://pubmed.ncbi.nlm.nih.gov/34599716/", "https://pubmed.ncbi.nlm.nih.gov/34115904/", "https://pubmed.ncbi.nlm.nih.gov/34247902/", "https://pubmed.ncbi.nlm.nih.gov/34696186/", "https://pubmed.ncbi.nlm.nih.gov/34237323/", "https://pubmed.ncbi.nlm.nih.gov/34851795/", "https://pubmed.ncbi.nlm.nih.gov/34849386/", "https://pubmed.ncbi.nlm.nih.gov/34310763/", "https://pubmed.ncbi.nlm.nih.gov/34251683/", "https://pubmed.ncbi.nlm.nih.gov/34557622/", "https://pubmed.ncbi.nlm.nih.gov/34510694/", "https://pubmed.ncbi.nlm.nih.gov/34713472/803", "https://pubmed.ncbi.nlm.nih.gov/34819272/", "https://pubmed.ncbi.nlm.nih.gov/34337124/", "https://pubmed.ncbi.nlm.nih.gov/34535924/", "https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/", "https://pubmed.ncbi.nlm.nih.gov/33591026/", "https://pubmed.ncbi.nlm.nih.gov/33625300/", "https://pubmed.ncbi.nlm.nih.gov/33774684/", "https://pubmed.ncbi.nlm.nih.gov/33985872/", "https://pubmed.ncbi.nlm.nih.gov/34735411/", "https://pubmed.ncbi.nlm.nih.gov/34115709/", "https://pubmed.ncbi.nlm.nih.gov/34257025/", "https://pubmed.ncbi.nlm.nih.gov/34836672/", "https://pubmed.ncbi.nlm.nih.gov/34280870/", "https://pubmed.ncbi.nlm.nih.gov/34432391/", "https://pubmed.ncbi.nlm.nih.gov/34731748/", "https://pubmed.ncbi.nlm.nih.gov/34906409/", "https://pubmed.ncbi.nlm.nih.gov/33706861/", "https://pubmed.ncbi.nlm.nih.gov/34116295/", "https://pubmed.ncbi.nlm.nih.gov/33661328/", "https://pubmed.ncbi.nlm.nih.gov/34050949/", "https://pubmed.ncbi.nlm.nih.gov/33624520/", "https://pubmed.ncbi.nlm.nih.gov/34141500/", "https://pubmed.ncbi.nlm.nih.gov/34096896/", "https://pubmed.ncbi.nlm.nih.gov/34835256/", "https://pubmed.ncbi.nlm.nih.gov/33713605/", "https://pubmed.ncbi.nlm.nih.gov/34298342/", "https://pubmed.ncbi.nlm.nih.gov/34839149/", "https://pubmed.ncbi.nlm.nih.gov/33685772/", "https://pubmed.ncbi.nlm.nih.gov/34719892/", "https://pubmed.ncbi.nlm.nih.gov/33625299/", "https://pubmed.ncbi.nlm.nih.gov/34292295/", "https://pubmed.ncbi.nlm.nih.gov/33947605/", "https://pubmed.ncbi.nlm.nih.gov/34526175/", "https://pubmed.ncbi.nlm.nih.gov/33786231/", "https://pubmed.ncbi.nlm.nih.gov/33625301/", "https://pubmed.ncbi.nlm.nih.gov/34332438/", "https://pubmed.ncbi.nlm.nih.gov/34342187/", "https://pubmed.ncbi.nlm.nih.gov/34601889/", "https://pubmed.ncbi.nlm.nih.gov/34081948/", "https://pubmed.ncbi.nlm.nih.gov/34507942/", "https://pubmed.ncbi.nlm.nih.gov/34362727/", "https://pubmed.ncbi.nlm.nih.gov/34325221/", "https://pubmed.ncbi.nlm.nih.gov/34825530/", "https://pubmed.ncbi.nlm.nih.gov/34000278/", "https://pubmed.ncbi.nlm.nih.gov/34655312/", "https://pubmed.ncbi.nlm.nih.gov/34187985/", "https://pubmed.ncbi.nlm.nih.gov/33706861/", "https://pubmed.ncbi.nlm.nih.gov/34116295/", "https://pubmed.ncbi.nlm.nih.gov/33661328/", "https://pubmed.ncbi.nlm.nih.gov/34050949/", "https://pubmed.ncbi.nlm.nih.gov/33624520/", "https://pubmed.ncbi.nlm.nih.gov/34141500/", "https://pubmed.ncbi.nlm.nih.gov/34096896/", "https://pubmed.ncbi.nlm.nih.gov/34835256/", "https://pubmed.ncbi.nlm.nih.gov/33713605/", "https://pubmed.ncbi.nlm.nih.gov/34298342/", "https://pubmed.ncbi.nlm.nih.gov/34839149/", "https://pubmed.ncbi.nlm.nih.gov/33685772/", "https://pubmed.ncbi.nlm.nih.gov/34719892/", "https://pubmed.ncbi.nlm.nih.gov/33625299/", "https://pubmed.ncbi.nlm.nih.gov/34292295/", "https://pubmed.ncbi.nlm.nih.gov/33947605/", "https://pubmed.ncbi.nlm.nih.gov/34526175/", "https://pubmed.ncbi.nlm.nih.gov/33786231/", "https://pubmed.ncbi.nlm.nih.gov/33625301/", "https://pubmed.ncbi.nlm.nih.gov/34332438/", "https://pubmed.ncbi.nlm.nih.gov/34342187/", "https://pubmed.ncbi.nlm.nih.gov/34601889/", "https://pubmed.ncbi.nlm.nih.gov/34081948/", "https://pubmed.ncbi.nlm.nih.gov/34507942/", "https://pubmed.ncbi.nlm.nih.gov/34362727/", "https://pubmed.ncbi.nlm.nih.gov/34325221/", "https://pubmed.ncbi.nlm.nih.gov/34825530/", "https://pubmed.ncbi.nlm.nih.gov/34000278/", "https://pubmed.ncbi.nlm.nih.gov/34655312/", "https://pubmed.ncbi.nlm.nih.gov/34187985/", "https://www.ncbi.nlm.nih.gov/pubmed/34416319", "https://www.ncbi.nlm.nih.gov/pubmed/34092429", "https://www.ncbi.nlm.nih.gov/pubmed/34025885", "https://www.ncbi.nlm.nih.gov/pubmed/34586408", "https://www.ncbi.nlm.nih.gov/pubmed/34756746", "https://www.ncbi.nlm.nih.gov/pubmed/34432976", "https://www.ncbi.nlm.nih.gov/pubmed/34754400", "https://www.ncbi.nlm.nih.gov/pubmed/34281357", "https://www.ncbi.nlm.nih.gov/pubmed/34835284", "https://www.ncbi.nlm.nih.gov/pubmed/34366403", "https://www.ncbi.nlm.nih.gov/pubmed/34564344", "https://www.ncbi.nlm.nih.gov/pubmed/34617315", "https://www.ncbi.nlm.nih.gov/pubmed/34333695", "https://www.ncbi.nlm.nih.gov/pubmed/34833382", "https://www.ncbi.nlm.nih.gov/pubmed/34704459", "https://www.ncbi.nlm.nih.gov/pubmed/34664804", "https://www.ncbi.nlm.nih.gov/pubmed/34860360", "https://www.ncbi.nlm.nih.gov/pubmed/34849657", "https://www.ncbi.nlm.nih.gov/pubmed/34933012", "https://www.ncbi.nlm.nih.gov/pubmed/34547487", "https://www.ncbi.nlm.nih.gov/pubmed/34339728", "https://www.ncbi.nlm.nih.gov/pubmed/34356586", "https://www.ncbi.nlm.nih.gov/pubmed/34219532", "https://www.ncbi.nlm.nih.gov/pubmed/34246585", "https://www.ncbi.nlm.nih.gov/pubmed/34492161", "https://www.ncbi.nlm.nih.gov/pubmed/34844930", "https://www.ncbi.nlm.nih.gov/pubmed/34487236", "https://www.ncbi.nlm.nih.gov/pubmed/34551225", "https://www.ncbi.nlm.nih.gov/pubmed/34709227", "https://www.ncbi.nlm.nih.gov/pubmed/34921468", "https://www.ncbi.nlm.nih.gov/pubmed/34824230", "https://www.ncbi.nlm.nih.gov/pubmed/34170372", "https://www.ncbi.nlm.nih.gov/pubmed/34849667", "https://www.ncbi.nlm.nih.gov/pubmed/34646267", "https://www.ncbi.nlm.nih.gov/pubmed/34127481", "https://www.ncbi.nlm.nih.gov/pubmed/34538306", "https://www.ncbi.nlm.nih.gov/pubmed/34237049", "https://www.ncbi.nlm.nih.gov/pubmed/33406694", "https://www.ncbi.nlm.nih.gov/pubmed/34660088", "https://www.ncbi.nlm.nih.gov/pubmed/34916217", "https://www.ncbi.nlm.nih.gov/pubmed/34153517", "https://www.ncbi.nlm.nih.gov/pubmed/34668687", "https://www.ncbi.nlm.nih.gov/pubmed/34348657", "https://www.ncbi.nlm.nih.gov/pubmed/34351881", "https://www.ncbi.nlm.nih.gov/pubmed/33854395", "https://www.ncbi.nlm.nih.gov/pubmed/34446426", "https://www.ncbi.nlm.nih.gov/pubmed/34808708", "https://www.ncbi.nlm.nih.gov/pubmed/34347278", "https://www.ncbi.nlm.nih.gov/pubmed/34544112https:/www.ncbi.nlm.nih.gov/pubmed/3454412", "https://www.ncbi.nlm.nih.gov/pubmed/34463755", "https://www.ncbi.nlm.nih.gov/pubmed/34931681", "https://www.ncbi.nlm.nih.gov/pubmed/34342500", "https://www.ncbi.nlm.nih.gov/pubmed/34805376", "https://www.ncbi.nlm.nih.gov/pubmed/34834983", "https://www.ncbi.nlm.nih.gov/pubmed/34389692", "https://www.ncbi.nlm.nih.gov/pubmed/34270752", "https://www.ncbi.nlm.nih.gov/pubmed/34744118", "https://www.ncbi.nlm.nih.gov/pubmed/34568540", "https://www.ncbi.nlm.nih.gov/pubmed/34447639", "https://www.ncbi.nlm.nih.gov/pubmed/34185046", "https://www.ncbi.nlm.nih.gov/pubmed/34402228", "https://www.ncbi.nlm.nih.gov/pubmed/34396358", "https://www.ncbi.nlm.nih.gov/pubmed/34477808", "https://www.ncbi.nlm.nih.gov/pubmed/33898162", "https://www.ncbi.nlm.nih.gov/pubmed/33643776", "https://www.ncbi.nlm.nih.gov/pubmed/34952008", "https://www.ncbi.nlm.nih.gov/pubmed/34642628", "https://www.ncbi.nlm.nih.gov/pubmed/34540594", "https://www.ncbi.nlm.nih.gov/pubmed/34378087", "https://www.ncbi.nlm.nih.gov/pubmed/34127854", "https://www.ncbi.nlm.nih.gov/pubmed/34393110", "https://www.ncbi.nlm.nih.gov/pubmed/34463770", "https://www.ncbi.nlm.nih.gov/pubmed/33606296", "https://www.ncbi.nlm.nih.gov/pubmed/34535317", "https://www.ncbi.nlm.nih.gov/pubmed/33888900", "https://www.ncbi.nlm.nih.gov/pubmed/34834458", "https://www.ncbi.nlm.nih.gov/pubmed/34778411", "https://www.ncbi.nlm.nih.gov/pubmed/34332972", "https://www.ncbi.nlm.nih.gov/pubmed/34375696", "https://www.ncbi.nlm.nih.gov/pubmed/34791081", "https://www.ncbi.nlm.nih.gov/pubmed/34676123", "https://www.ncbi.nlm.nih.gov/pubmed/34398511", "https://www.ncbi.nlm.nih.gov/pubmed/33316478", "https://www.ncbi.nlm.nih.gov/pubmed/34133825", "https://www.ncbi.nlm.nih.gov/pubmed/34614328", "https://www.ncbi.nlm.nih.gov/pubmed/34166671", "https://www.ncbi.nlm.nih.gov/pubmed/34737312", "https://www.ncbi.nlm.nih.gov/pubmed/33526560", "https://www.ncbi.nlm.nih.gov/pubmed/34930152", "https://www.ncbi.nlm.nih.gov/pubmed/34185045", "https://www.ncbi.nlm.nih.gov/pubmed/34840235", "https://www.ncbi.nlm.nih.gov/pubmed/34876937", "https://www.ncbi.nlm.nih.gov/pubmed/34089859", "https://www.ncbi.nlm.nih.gov/pubmed/34889875", "https://www.ncbi.nlm.nih.gov/pubmed/34320609", "https://www.ncbi.nlm.nih.gov/pubmed/34402230", "https://www.ncbi.nlm.nih.gov/pubmed/34180390", "https://www.ncbi.nlm.nih.gov/pubmed/34496880", "https://www.ncbi.nlm.nih.gov/pubmed/34907393", "https://www.ncbi.nlm.nih.gov/pubmed/34367386", "https://www.ncbi.nlm.nih.gov/pubmed/34734240", "https://www.ncbi.nlm.nih.gov/pubmed/34738774", "https://www.ncbi.nlm.nih.gov/pubmed/34695229", "https://www.ncbi.nlm.nih.gov/pubmed/34233234", "https://www.ncbi.nlm.nih.gov/pubmed/34934954", "https://www.ncbi.nlm.nih.gov/pubmed/34228985", "https://www.ncbi.nlm.nih.gov/pubmed/34591186", "https://www.ncbi.nlm.nih.gov/pubmed/34241676", "https://www.ncbi.nlm.nih.gov/pubmed/34945172", "https://www.ncbi.nlm.nih.gov/pubmed/34707602", "https://www.ncbi.nlm.nih.gov/pubmed/33956784", "https://www.ncbi.nlm.nih.gov/pubmed/34408937", "https://www.ncbi.nlm.nih.gov/pubmed/34739045", "https://www.ncbi.nlm.nih.gov/pubmed/34605853", "https://www.ncbi.nlm.nih.gov/pubmed/34341797", "https://www.ncbi.nlm.nih.gov/pubmed/34764489", "https://www.ncbi.nlm.nih.gov/pubmed/34077949", "https://www.ncbi.nlm.nih.gov/pubmed/34911654", "https://www.ncbi.nlm.nih.gov/pubmed/34282971", "https://www.ncbi.nlm.nih.gov/pubmed/34420869", "https://www.ncbi.nlm.nih.gov/pubmed/34514306", "https://www.ncbi.nlm.nih.gov/pubmed/34955479", "https://www.ncbi.nlm.nih.gov/pubmed/33444297", "https://www.ncbi.nlm.nih.gov/pubmed/34192428", "https://www.ncbi.nlm.nih.gov/pubmed/34866957", "https://www.ncbi.nlm.nih.gov/pubmed/34865500", "https://www.ncbi.nlm.nih.gov/pubmed/34311983", "https://www.ncbi.nlm.nih.gov/pubmed/34904134", "https://www.ncbi.nlm.nih.gov/pubmed/34277198", "https://www.ncbi.nlm.nih.gov/pubmed/34731877", "https://www.ncbi.nlm.nih.gov/pubmed/34533570", "https://www.ncbi.nlm.nih.gov/pubmed/34229940", "https://www.ncbi.nlm.nih.gov/pubmed/34336774", "https://www.ncbi.nlm.nih.gov/pubmed/34006408", "https://www.ncbi.nlm.nih.gov/pubmed/34614329", "https://www.ncbi.nlm.nih.gov/pubmed/33262177", "https://www.saveusnow.org.uk/covid-vaccine-scientific-proof-lethal/", "https://www.globalresearch.ca/author/sun", "https://www.saveusnow.org.uk/covid-vaccine-scientific-proof-lethal/", "https://www.facebook.com/GlobalResearchCRG", "https://store.globalresearch.ca/member/"], "authors": [], "publish_date": "2023-04-15T15:02:30+00:00"}